These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Fiscal Year Ended December 31, 2015
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Transition Period from to
|
|
|
|
|
|
Delaware
|
|
76-0346924
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value
|
|
New York Stock Exchange, Inc.
|
|
|
|
Large accelerated filer
x
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
|
Product
|
|
Annual Capacity
|
|
End Uses
|
|
|
|
|
(Millions of pounds)
|
|
|
|
|
Ethylene
(1)
|
|
2,740
|
|
|
Polyethylene, ethylene dichloride ("EDC"), styrene,
ethylene oxide/ethylene glycol
|
|
Low-Density Polyethylene ("LDPE")
|
|
1,500
|
|
|
High clarity packaging, shrink films, laundry and dry
cleaning bags, ice bags, frozen foods packaging, bakery
bags, coated paper board, cup stock, paper folding
cartons, lids, closures and general purpose molding
|
|
Linear Low-Density Polyethylene
("LLDPE")
|
|
1,070
|
|
|
Heavy-duty films and bags, general purpose liners
|
|
Styrene
|
|
570
|
|
|
Consumer disposables, packaging material, appliances,
paints and coatings, resins and building materials
|
|
(1)
|
Production capacity owned by OpCo.
|
|
Product
(1)
|
|
Annual Capacity
(2)
|
|
End Uses
|
|
|
|
|
(Millions of pounds)
|
|
|
|
|
Specialty PVC
|
|
1,100
|
|
|
Automotive sealants, cable sheathing, medical
applications and other consumer applications
|
|
Commodity PVC
|
|
2,820
|
|
|
Construction materials including pipe, siding, profiles for
windows and doors, film and sheet for packaging
and other consumer applications
|
|
VCM
|
|
3,320
|
|
|
PVC
|
|
Chlorine
|
|
2,200
|
|
|
VCM, organic/inorganic chemicals, bleach
|
|
Caustic Soda
|
|
2,420
|
|
|
Pulp and paper, organic/inorganic chemicals,
neutralization, alumina
|
|
Ethylene
(3)
|
|
630
|
|
|
VCM
|
|
Building Products
|
|
1,280
|
|
|
Pipe: water and sewer, plumbing, irrigation, conduit;
fittings; profiles and foundation building products;
window and door components; fence and deck
components; film and sheet
|
|
(1)
|
EDC, a VCM intermediate product, is not included in the table.
|
|
(2)
|
Includes capacity related to our
95%
owned Asian joint venture.
|
|
(3)
|
Production capacity owned by OpCo.
|
|
•
|
emissions to the air;
|
|
•
|
discharges to land or to surface and subsurface waters;
|
|
•
|
other releases into the environment;
|
|
•
|
remediation of contaminated sites;
|
|
•
|
generation, handling, storage, transportation, treatment and disposal of waste materials; and
|
|
•
|
maintenance of safe conditions in the workplace.
|
|
Category
|
|
Number
|
|
|
Olefins segment
|
|
1,000
|
|
|
Vinyls segment
|
|
3,050
|
|
|
Corporate and other
|
|
175
|
|
|
•
|
general economic conditions, including in the United States, Europe and Asia;
|
|
•
|
new capacity additions in North America, Asia and the Middle East;
|
|
•
|
the level of business activity in the industries that use our products;
|
|
•
|
competitor action;
|
|
•
|
technological innovations;
|
|
•
|
currency fluctuations;
|
|
•
|
increases in interest rates;
|
|
•
|
international events and circumstances;
|
|
•
|
war, terrorism and civil unrest;
|
|
•
|
governmental regulation, including in the United States, Europe and Asia;
|
|
•
|
severe weather and natural disasters; and
|
|
•
|
credit worthiness of customers and vendors.
|
|
•
|
product price;
|
|
•
|
technical support and customer service;
|
|
•
|
quality;
|
|
•
|
reliability of raw material and utility supply;
|
|
•
|
availability of potential substitute materials; and
|
|
•
|
product performance.
|
|
•
|
the emergence of new domestic and international competitors;
|
|
•
|
the rate of capacity additions by competitors;
|
|
•
|
changes in customer base due to mergers;
|
|
•
|
the intensification of price competition in our markets;
|
|
•
|
the introduction of new or substitute products by competitors; and
|
|
•
|
the technological innovations of competitors.
|
|
•
|
pipeline leaks and ruptures;
|
|
•
|
explosions;
|
|
•
|
fires;
|
|
•
|
severe weather and natural disasters;
|
|
•
|
mechanical failure;
|
|
•
|
unscheduled downtime;
|
|
•
|
labor difficulties;
|
|
•
|
transportation interruptions;
|
|
•
|
chemical spills;
|
|
•
|
discharges or releases of toxic or hazardous substances or gases;
|
|
•
|
storage tank leaks;
|
|
•
|
other environmental risks;
|
|
•
|
terrorist attacks; and
|
|
•
|
political unrest.
|
|
•
|
unexpectedly long delivery times for, or shortages of, key equipment, parts or materials;
|
|
•
|
shortages of skilled labor and other personnel necessary to perform the work;
|
|
•
|
delays and performance issues;
|
|
•
|
failures or delays of third-party equipment vendors or service providers;
|
|
•
|
unforeseen increases in the cost of equipment, labor and raw materials;
|
|
•
|
work stoppages and other labor disputes;
|
|
•
|
unanticipated actual or purported change orders;
|
|
•
|
disputes with contractors and suppliers;
|
|
•
|
design and engineering problems;
|
|
•
|
latent damages or deterioration to equipment and machinery in excess of engineering estimates and assumptions;
|
|
•
|
financial or other difficulties of our contractors and suppliers;
|
|
•
|
interference from adverse weather conditions; and
|
|
•
|
difficulties in obtaining necessary permits or in meeting permit conditions.
|
|
•
|
a portion of our cash flow from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes, including the payment of dividends;
|
|
•
|
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
|
|
•
|
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flow to improve their operations;
|
|
•
|
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
|
|
•
|
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
|
|
•
|
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
|
|
•
|
pay dividends on, redeem or repurchase our capital stock;
|
|
•
|
make investments and other restricted payments;
|
|
•
|
incur additional indebtedness or issue preferred stock;
|
|
•
|
create liens;
|
|
•
|
permit dividend or other payment restrictions on our restricted subsidiaries;
|
|
•
|
sell all or substantially all of our assets or consolidate or merge with or into other companies;
|
|
•
|
engage in transactions with affiliates; and
|
|
•
|
engage in sale-leaseback transactions.
|
|
•
|
we may fail to integrate the businesses we acquire into a cohesive, efficient enterprise;
|
|
•
|
our resources, including management resources, are limited and may be strained if we engage in a large acquisition or significant number of acquisitions, and acquisitions may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; and
|
|
•
|
our failure to retain key employees and contracts of the businesses we acquire.
|
|
•
|
the composition of our Board of Directors and, through the Board, any determination with respect to our business direction and policies, including the appointment and removal of officers and the determination of compensation;
|
|
•
|
any determinations with respect to mergers or other business combinations or the acquisition or disposition of assets;
|
|
•
|
our financing decisions, capital raising activities and the payment of dividends; and
|
|
•
|
amendments to our amended and restated certificate of incorporation or amended and restated bylaws.
|
|
•
|
business opportunities that may be presented to the principal stockholder affiliates and to our officers and directors associated with the principal stockholder affiliates, and competition between the principal stockholder affiliates and us within the same lines of business;
|
|
•
|
the solicitation and hiring of employees from each other; and
|
|
•
|
agreements with the principal stockholder affiliates relating to corporate services that may be material to our business.
|
|
•
|
future operating rates, margins, cash flow and demand for our products;
|
|
•
|
industry market outlook, including the price of crude oil;
|
|
•
|
production capacities;
|
|
•
|
currency devaluation;
|
|
•
|
our ability to borrow additional funds under our credit facility;
|
|
•
|
our ability to meet our liquidity needs;
|
|
•
|
our ability to meet debt obligations under our debt instruments;
|
|
•
|
our intended quarterly dividends;
|
|
•
|
future capacity additions and expansions in the industry;
|
|
•
|
timing, funding and results of capital projects, such as the expansion programs at our Lake Charles and Calvert City facilities;
|
|
•
|
results of acquisitions;
|
|
•
|
health of our customer base;
|
|
•
|
pension plan obligations, funding requirements and investment policies;
|
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other GHG emissions or to address other issues of climate change;
|
|
•
|
effects of pending legal proceedings; and
|
|
•
|
timing of and amount of capital expenditures.
|
|
•
|
general economic and business conditions;
|
|
•
|
the cyclical nature of the chemical industry;
|
|
•
|
the availability, cost and volatility of raw materials and energy;
|
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
|
•
|
current and potential governmental regulatory actions in the United States, Europe and Asia and regulatory actions and political unrest in other areas;
|
|
•
|
industry production capacity and operating rates;
|
|
•
|
the supply/demand balance for our products;
|
|
•
|
competitive products and pricing pressures;
|
|
•
|
instability in the credit and financial markets;
|
|
•
|
access to capital markets;
|
|
•
|
terrorist acts;
|
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
|
•
|
changes in laws or regulations;
|
|
•
|
technological developments;
|
|
•
|
our ability to integrate acquired businesses;
|
|
•
|
foreign currency exchange risks;
|
|
•
|
our ability to implement our business strategies; and
|
|
•
|
creditworthiness of our customers.
|
|
Location
|
|
Principal Products
|
|
Lake Charles, Louisiana
|
|
Ethylene, polyethylene, styrene
|
|
Longview, Texas
(1)
|
|
Polyethylene, polyethylene wax
|
|
Calvert City, Kentucky
(2)
|
|
PVC, VCM, EDC, chlorine, caustic soda, ethylene
|
|
Geismar, Louisiana
|
|
PVC, VCM, EDC, chlorine, caustic soda
|
|
Gendorf, Bavaria, Germany
(1)
|
|
PVC, VCM, EDC, chlorine, caustic soda
|
|
Burghausen, Bavaria, Germany
(1)
|
|
PVC
|
|
Knapsack, North Rhine-Westphalia, Germany
(1)
|
|
PVC, VCM, EDC, chlorine, caustic soda
|
|
Cologne, North Rhine-Westphalia, Germany
(1)
|
|
PVC
|
|
Schkopau, Saxony-Anhalt, Germany
(1)
|
|
PVC
|
|
Hillhouse, Lancashire, United Kingdom
(1)
|
|
PVC
|
|
Suzhou, Jiangsu, in the People's Republic of China
(1)
|
|
PVC, PVC film and sheet
|
|
Booneville, Mississippi
|
|
PVC pipe
|
|
Greensboro, Georgia
|
|
PVC pipe
|
|
Janesville, Wisconsin
|
|
PVC pipe
|
|
Leola, Pennsylvania
|
|
PVC pipe
|
|
Wichita Falls, Texas
|
|
PVC pipe
|
|
Yucca, Arizona
|
|
PVC pipe
|
|
Lodi, California
|
|
PVC pipe and fittings
|
|
McPherson, Kansas
|
|
PVC pipe and fittings
|
|
Evansville, Indiana
|
|
Fence and deck components
|
|
Calgary, Alberta, Canada
(3)
|
|
Window and door components
|
|
(1)
|
We lease the land on which our facilities are located. The Suzhou facility is our
95%
owned Asian joint venture.
|
|
(2)
|
We lease a portion of the land on which our Calvert City facility is located.
|
|
(3)
|
We lease our Calgary land and building.
|
|
|
|
High
|
|
Low
|
|
Cash Dividends
Declared
|
||||||
|
Year Ended December 31, 2015
|
|
|
|
|
|
|
||||||
|
4th Quarter
|
|
$
|
62.09
|
|
|
$
|
52.86
|
|
|
$
|
0.1815
|
|
|
3rd Quarter
|
|
66.69
|
|
|
49.82
|
|
|
0.1815
|
|
|||
|
2nd Quarter
|
|
78.59
|
|
|
67.98
|
|
|
0.1650
|
|
|||
|
1st Quarter
|
|
72.49
|
|
|
55.20
|
|
|
0.1650
|
|
|||
|
Year Ended December 31, 2014
|
|
|
|
|
|
|
||||||
|
4th Quarter
|
|
$
|
83.43
|
|
|
$
|
53.67
|
|
|
$
|
0.1650
|
|
|
3rd Quarter
|
|
97.96
|
|
|
84.22
|
|
|
0.1650
|
|
|||
|
2nd Quarter
|
|
84.77
|
|
|
62.36
|
|
|
0.1260
|
|
|||
|
1st Quarter
|
|
68.73
|
|
|
57.66
|
|
|
0.1260
|
|
|||
|
Period
|
|
Total Number
of Shares
Purchased
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(1)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(1)
|
||||||
|
October 2015
|
|
288,161
|
|
|
$
|
55.33
|
|
|
288,161
|
|
|
$
|
113,533,000
|
|
|
November 2015
|
|
327,283
|
|
|
$
|
59.46
|
|
|
327,283
|
|
|
$
|
244,073,000
|
|
|
December 2015
|
|
111,741
|
|
|
$
|
54.53
|
|
|
111,174
|
|
|
$
|
238,012,000
|
|
|
Total
|
|
727,185
|
|
|
$
|
56.27
|
|
|
726,618
|
|
|
|
||
|
(1)
|
In November 2014, our Board of Directors approved a $250.0 million stock repurchase program (the "2014 Program"). On November 20, 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150.0 million. As of
December 31, 2015
,
2,682,489
shares of our common stock had been acquired at an aggregate purchase price of approximately
$162.0 million
under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
|
Plan Category
|
|
Number of securities
to be issued upon
exercise of outstanding options,
warrants and rights
(a)
|
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
|
Number of securities
remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column
(a))
(c)
|
||||
|
Equity compensation plans approved by security holders
|
|
1,766,662
|
|
|
$
|
21.58
|
|
|
5,733,600
|
|
|
Equity compensation plans not approved by security holders
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
|
Total
|
|
1,766,662
|
|
|
$
|
21.58
|
|
|
5,733,600
|
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(dollars in thousands, except share amounts, per share data and volume data)
|
||||||||||||||||||
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net sales
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
$
|
3,571,041
|
|
|
$
|
3,619,848
|
|
|
Gross profit
|
|
1,185,191
|
|
|
1,317,350
|
|
|
1,101,438
|
|
|
736,960
|
|
|
559,006
|
|
|||||
|
Selling, general and administrative expenses
|
|
225,364
|
|
|
193,359
|
|
|
147,974
|
|
|
121,609
|
|
|
112,210
|
|
|||||
|
Income from operations
|
|
959,827
|
|
|
1,123,991
|
|
|
953,464
|
|
|
615,351
|
|
|
446,796
|
|
|||||
|
Interest expense
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|
(43,049
|
)
|
|
(50,992
|
)
|
|||||
|
Debt retirement costs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,082
|
)
|
|
—
|
|
|||||
|
Gain from sales of equity securities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,429
|
|
|
—
|
|
|||||
|
Other income (expense), net
(2)
|
|
38,270
|
|
|
(2,721
|
)
|
|
6,790
|
|
|
3,520
|
|
|
5,628
|
|
|||||
|
Income before income taxes
|
|
963,441
|
|
|
1,083,918
|
|
|
942,172
|
|
|
585,169
|
|
|
401,432
|
|
|||||
|
Provision for income taxes
|
|
298,396
|
|
|
398,902
|
|
|
331,747
|
|
|
199,614
|
|
|
142,466
|
|
|||||
|
Net income
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|
385,555
|
|
|
258,966
|
|
|||||
|
Net income attributable to noncontrolling
interests
|
|
19,035
|
|
|
6,493
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
|
$
|
610,425
|
|
|
$
|
385,555
|
|
|
$
|
258,966
|
|
|
Earnings Per Share Attributable to
Westlake Chemical Corporation:
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
|
$
|
4.57
|
|
|
$
|
2.89
|
|
|
$
|
1.95
|
|
|
Diluted
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
|
$
|
2.88
|
|
|
$
|
1.94
|
|
|
Weighted average shares outstanding
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
131,823,707
|
|
|
133,111,230
|
|
|
133,224,256
|
|
|
132,578,858
|
|
|
131,854,842
|
|
|||||
|
Diluted
|
|
132,301,812
|
|
|
133,643,414
|
|
|
133,779,250
|
|
|
133,282,990
|
|
|
132,600,316
|
|
|||||
|
Balance Sheet Data (end of period):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents
|
|
$
|
662,525
|
|
|
$
|
880,601
|
|
|
$
|
461,301
|
|
|
$
|
790,078
|
|
|
$
|
825,901
|
|
|
Marketable securities
|
|
520,144
|
|
|
—
|
|
|
239,388
|
|
|
124,873
|
|
|
—
|
|
|||||
|
Restricted cash
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
96,283
|
|
|||||
|
Working capital
(4)
|
|
1,652,547
|
|
|
1,474,107
|
|
|
1,244,224
|
|
|
1,352,903
|
|
|
1,391,561
|
|
|||||
|
Total assets
|
|
5,575,252
|
|
|
5,213,990
|
|
|
4,060,909
|
|
|
3,412,196
|
|
|
3,266,821
|
|
|||||
|
Total debt
|
|
764,115
|
|
|
763,997
|
|
|
763,879
|
|
|
763,761
|
|
|
764,563
|
|
|||||
|
Total Westlake Chemical Corporation
stockholders' equity
|
|
3,265,878
|
|
|
2,911,511
|
|
|
2,418,603
|
|
|
1,872,256
|
|
|
1,756,312
|
|
|||||
|
Cash dividends declared per share
(3) (5)
|
|
$
|
0.6930
|
|
|
$
|
0.5820
|
|
|
$
|
0.4125
|
|
|
$
|
2.1363
|
|
|
$
|
0.1373
|
|
|
Other Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash flow from:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating activities
|
|
$
|
1,078,836
|
|
|
$
|
1,032,376
|
|
|
$
|
752,729
|
|
|
$
|
612,087
|
|
|
$
|
358,935
|
|
|
Investing activities
|
|
(1,006,176
|
)
|
|
(773,205
|
)
|
|
(1,002,238
|
)
|
|
(466,971
|
)
|
|
(202,785
|
)
|
|||||
|
Financing activities
|
|
(286,812
|
)
|
|
164,640
|
|
|
(79,268
|
)
|
|
(180,939
|
)
|
|
39,452
|
|
|||||
|
Depreciation and amortization
|
|
245,757
|
|
|
208,486
|
|
|
157,808
|
|
|
144,541
|
|
|
131,397
|
|
|||||
|
Capital expenditures
|
|
491,426
|
|
|
431,104
|
|
|
679,222
|
|
|
386,882
|
|
|
176,843
|
|
|||||
|
EBITDA
(6)
|
|
1,243,854
|
|
|
1,329,756
|
|
|
1,118,062
|
|
|
772,759
|
|
|
583,821
|
|
|||||
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(dollars in thousands, except share amounts, per share data and volume data)
|
||||||||||||||||||
|
External Sales Volume
(millions of pounds):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Olefins Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Polyethylene
|
|
2,445
|
|
|
2,364
|
|
|
2,244
|
|
|
2,230
|
|
|
2,272
|
|
|||||
|
Styrene, feedstock and other
|
|
1,182
|
|
|
941
|
|
|
1,094
|
|
|
925
|
|
|
753
|
|
|||||
|
Vinyls Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
PVC, caustic soda and other
|
|
5,026
|
|
|
3,174
|
|
|
1,995
|
|
|
1,822
|
|
|
1,749
|
|
|||||
|
Building products
|
|
629
|
|
|
572
|
|
|
487
|
|
|
423
|
|
|
403
|
|
|||||
|
(1)
|
The historical selected financial and operational data should be read together with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 8, Financial Statements and Supplementary Data included in this Form 10-K.
|
|
(2)
|
Other income (expense), net is composed of interest income, income or loss from equity method investments, dividend income, gains or losses from sales of securities, foreign exchange currency gains or losses, gain on acquisition, impairment of equity method investments, management fee income and other gains and losses.
|
|
(3)
|
On February 14, 2014, our Board of Directors authorized a two-for-one split of our common stock. Stockholders of record as of February 28, 2014 were entitled to one additional share for every share outstanding, which was distributed on March 18, 2014. All share amounts and per share data for the years prior to December 31, 2014 have been restated to reflect the effect of the two-for-one stock split.
|
|
(4)
|
Working capital equals current assets less current liabilities.
|
|
(5)
|
Cash dividends declared for the year ended December 31, 2012 includes a special dividend of $1.875 per share (on a post-split basis) paid on December 12, 2012.
|
|
(6)
|
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose a non-GAAP financial measure is generally defined by the SEC as one that purports to measure historical and future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. We have included EBITDA in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. EBITDA allows for meaningful company-to-company performance comparisons by adjusting for factors such as interest expense, depreciation and amortization and taxes, which often vary from company to company. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flow and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented in this Form 10-K may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which is a necessary element of our operations. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only supplementally. The following table reconciles EBITDA to net income and to net cash provided by operating activities.
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(dollars in thousands)
|
||||||||||||||||||
|
EBITDA
|
|
$
|
1,243,854
|
|
|
$
|
1,329,756
|
|
|
$
|
1,118,062
|
|
|
$
|
772,759
|
|
|
$
|
583,821
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Provision for income taxes
|
|
(298,396
|
)
|
|
(398,902
|
)
|
|
(331,747
|
)
|
|
(199,614
|
)
|
|
(142,466
|
)
|
|||||
|
Interest expense
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|
(43,049
|
)
|
|
(50,992
|
)
|
|||||
|
Depreciation and amortization
|
|
(245,757
|
)
|
|
(208,486
|
)
|
|
(157,808
|
)
|
|
(144,541
|
)
|
|
(131,397
|
)
|
|||||
|
Net income
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|
385,555
|
|
|
258,966
|
|
|||||
|
Changes in operating assets and liabilities
and other
|
|
371,794
|
|
|
273,083
|
|
|
34,453
|
|
|
244,683
|
|
|
76,898
|
|
|||||
|
(Income) loss from equity method investments
|
|
(632
|
)
|
|
(424
|
)
|
|
199
|
|
|
3,005
|
|
|
(427
|
)
|
|||||
|
Windfall tax benefits from share-based
payment arrangements
|
|
(1,646
|
)
|
|
(6,704
|
)
|
|
(5,449
|
)
|
|
(11,967
|
)
|
|
(3,361
|
)
|
|||||
|
Deferred income taxes
|
|
39,784
|
|
|
58,967
|
|
|
93,732
|
|
|
(5,793
|
)
|
|
14,114
|
|
|||||
|
Write-off of debt issuance costs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,277
|
|
|
—
|
|
|||||
|
Impairment of equity method investments
|
|
4,925
|
|
|
6,747
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Impairment of long-lived assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,975
|
|
|||||
|
(Gains) losses from sales of securities
|
|
(3,798
|
)
|
|
(1,212
|
)
|
|
19
|
|
|
(16,429
|
)
|
|
—
|
|
|||||
|
Gain on acquisition, net of loss on the fair value
remeasurement of preexisting equity interest
|
|
(21,045
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Loss from disposition of fixed assets
|
|
10,891
|
|
|
4,181
|
|
|
5,039
|
|
|
3,886
|
|
|
1,375
|
|
|||||
|
Stock-based compensation expense
|
|
10,196
|
|
|
9,261
|
|
|
6,966
|
|
|
6,127
|
|
|
6,391
|
|
|||||
|
Amortization of debt issuance costs
|
|
2,004
|
|
|
1,673
|
|
|
1,459
|
|
|
1,514
|
|
|
1,683
|
|
|||||
|
Provision for doubtful accounts
|
|
956
|
|
|
301
|
|
|
5,514
|
|
|
229
|
|
|
1,321
|
|
|||||
|
Other losses, net
|
|
362
|
|
|
1,487
|
|
|
372
|
|
|
—
|
|
|
—
|
|
|||||
|
Net cash provided by operating activities
|
|
$
|
1,078,836
|
|
|
$
|
1,032,376
|
|
|
$
|
752,729
|
|
|
$
|
612,087
|
|
|
$
|
358,935
|
|
|
•
|
the availability of feedstock from shale gas and oil drilling;
|
|
•
|
supply and demand for crude oil;
|
|
•
|
shortages of raw materials due to increasing demand;
|
|
•
|
ethane and liquefied natural gas exports;
|
|
•
|
capacity constraints due to higher construction costs for investments, construction delays, strike action or involuntary shutdowns;
|
|
•
|
the general level of business and economic activity; and
|
|
•
|
the direct or indirect effect of governmental regulation.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
(dollars in thousands, except per share data)
|
||||||||||
|
Net external sales
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
|
|
|
|
|
||||||
|
Polyethylene
|
|
$
|
1,650,964
|
|
|
$
|
1,922,535
|
|
|
$
|
1,750,292
|
|
|
Styrene, feedstock and other
|
|
609,149
|
|
|
801,155
|
|
|
803,377
|
|
|||
|
Total Olefins
|
|
2,260,113
|
|
|
2,723,690
|
|
|
2,553,669
|
|
|||
|
Vinyls
|
|
|
|
|
|
|
||||||
|
PVC, caustic soda and other
|
|
1,718,359
|
|
|
1,203,332
|
|
|
800,658
|
|
|||
|
Building products
|
|
484,864
|
|
|
488,328
|
|
|
405,157
|
|
|||
|
Total Vinyls
|
|
2,203,223
|
|
|
1,691,660
|
|
|
1,205,815
|
|
|||
|
Total
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
|
|
|
|
|
|
|
||||||
|
Income (loss) from operations
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
747,436
|
|
|
$
|
1,013,825
|
|
|
$
|
833,249
|
|
|
Vinyls
|
|
254,452
|
|
|
142,740
|
|
|
154,684
|
|
|||
|
Corporate and other
|
|
(42,061
|
)
|
|
(32,574
|
)
|
|
(34,469
|
)
|
|||
|
Total income from operations
|
|
959,827
|
|
|
1,123,991
|
|
|
953,464
|
|
|||
|
Interest expense
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|||
|
Other income (expense), net
|
|
38,270
|
|
|
(2,721
|
)
|
|
6,790
|
|
|||
|
Provision for income taxes
|
|
298,396
|
|
|
398,902
|
|
|
331,747
|
|
|||
|
Net income
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|||
|
Net income attributable to noncontrolling interests
|
|
19,035
|
|
|
6,493
|
|
|
—
|
|
|||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
|
$
|
610,425
|
|
|
Diluted earnings per share
(1)
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
|
(1)
|
Per share data for the year ended
December 31,
2013
has been restated to reflect the effect of a two-for-one stock split on March 18, 2014. See Note 9 to the consolidated financial statements for additional information.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
||||||||
|
|
|
Average Sales
Price
|
|
Volume
|
|
Average Sales
Price
|
|
Volume
|
||||
|
Product sales price and volume percentage change
from prior year
|
|
|
|
|
|
|
|
|
||||
|
Olefins
|
|
-29.2
|
%
|
|
+12.2
|
%
|
|
+7.4
|
%
|
|
-0.8
|
%
|
|
Vinyls
|
|
-18.9
|
%
|
|
+49.1
|
%
|
|
+0.6
|
%
|
|
+39.7
|
%
|
|
Company average
|
|
-25.3
|
%
|
|
+26.3
|
%
|
|
+5.2
|
%
|
|
+12.2
|
%
|
|
|
|
Year Ended December 31,
|
|||||||
|
|
|
2015
|
|
2014
|
|
2013
|
|||
|
Average industry prices
(1)
|
|
|
|
|
|
|
|||
|
Ethane (cents/lb)
|
|
6.2
|
|
|
9.0
|
|
|
8.8
|
|
|
Propane (cents/lb)
|
|
10.7
|
|
|
24.7
|
|
|
23.7
|
|
|
Ethylene (cents/lb)
(2)
|
|
30.6
|
|
|
58.4
|
|
|
57.1
|
|
|
Polyethylene (cents/lb)
(3)
|
|
75.3
|
|
|
87.8
|
|
|
80.0
|
|
|
Styrene (cents/lb)
(4)
|
|
60.7
|
|
|
82.1
|
|
|
83.2
|
|
|
Caustic ($/short ton)
(5)
|
|
581.0
|
|
|
589.4
|
|
|
604.2
|
|
|
Chlorine ($/short ton)
(6)
|
|
266.9
|
|
|
233.5
|
|
|
250.8
|
|
|
PVC (cents/lb)
(7)
|
|
66.0
|
|
|
68.8
|
|
|
60.8
|
|
|
(1)
|
Industry pricing data was obtained through IHS Chemical. We have not independently verified the data.
|
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
|
(3)
|
Represents average North American contract prices of polyethylene low density GP-Film grade over the period as reported by IHS Chemical. Effective January 1, 2015, IHS Chemical made a non-market downward adjustment of 21 cents per pound to polyethylene low density GP-Film grade prices. For comparability, we adjusted each prior-year period's polyethylene low density GP-Film grade price downward by 21 cents per pound consistent with the IHS Chemical non-market adjustment.
|
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS Chemical.
|
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS Chemical. During the first quarter of 2013, IHS Chemical discontinued the previous caustic soda industry index that we used. For comparability, the average 2012 caustic data is based on the current index.
|
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS Chemical.
|
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS Chemical.
|
|
|
|
Payment Due by Period
|
||||||||||||||||||
|
|
|
Total
|
|
2016
|
|
2017-2018
|
|
2019-2020
|
|
Thereafter
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(dollars in millions)
|
||||||||||||||||||
|
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Long-term debt
|
|
$
|
764.1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
764.1
|
|
|
Operating leases
|
|
756.2
|
|
|
43.2
|
|
|
77.4
|
|
|
53.3
|
|
|
582.3
|
|
|||||
|
Capital leases
|
|
2.0
|
|
|
0.2
|
|
|
0.5
|
|
|
0.5
|
|
|
0.8
|
|
|||||
|
Pension benefits funding
|
|
92.1
|
|
|
4.4
|
|
|
5.8
|
|
|
6.7
|
|
|
75.2
|
|
|||||
|
Post-retirement healthcare benefits
|
|
12.8
|
|
|
1.2
|
|
|
2.8
|
|
|
2.8
|
|
|
6.0
|
|
|||||
|
Purchase obligations
|
|
6,998.1
|
|
|
1,283.8
|
|
|
964.4
|
|
|
812.4
|
|
|
3,937.5
|
|
|||||
|
Interest payments
|
|
630.8
|
|
|
42.4
|
|
|
84.8
|
|
|
84.8
|
|
|
418.8
|
|
|||||
|
Total
|
|
$
|
9,256.1
|
|
|
$
|
1,375.2
|
|
|
$
|
1,135.7
|
|
|
$
|
960.5
|
|
|
$
|
5,784.7
|
|
|
Other Commercial Commitments
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Standby letters of credit
|
|
$
|
35.5
|
|
|
$
|
30.1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5.4
|
|
|
|
|
2015
|
||||||
|
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||
|
|
|
|
|
|
||||
|
|
|
(dollars in millions)
|
||||||
|
Projected benefit obligation, end of year
|
|
$
|
62.2
|
|
|
$
|
94.8
|
|
|
Discount rate increases by 100 basis points
|
|
55.6
|
|
|
81.3
|
|
||
|
Discount rate decreases by 100 basis points
|
|
70.1
|
|
|
112.2
|
|
||
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
|
Page
|
|
|
|
|
Management's Report on Internal Control over Financial Reporting
|
|
|
Report of Independent Registered Public Accounting Firm
|
|
|
Consolidated Financial Statements:
|
|
|
Consolidated Balance Sheets as of December 31, 2015 and 2014
|
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2015, 2014 and 2013
|
|
|
Consolidated Statements of Comprehensive Income for the Years Ended
December 31, 2015, 2014 and 2013
|
|
|
Consolidated Statements of Changes in Stockholders' Equity for the Years Ended
December 31, 2015, 2014 and 2013
|
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2015, 2014 and 2013
|
|
|
Notes to Consolidated Financial Statements
|
|
|
Financial Statement Schedule II—Valuation and Qualifying Accounts
|
|
|
|
|
December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
|
|
|
|
|
||||
|
|
|
(in thousands of dollars, except
par values and share amounts)
|
||||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
662,525
|
|
|
$
|
880,601
|
|
|
Marketable securities
|
|
520,144
|
|
|
—
|
|
||
|
Accounts receivable, net
|
|
508,532
|
|
|
560,666
|
|
||
|
Inventories
|
|
434,060
|
|
|
525,776
|
|
||
|
Prepaid expenses and other current assets
|
|
14,489
|
|
|
11,807
|
|
||
|
Deferred income taxes
|
|
35,439
|
|
|
32,437
|
|
||
|
Total current assets
|
|
2,175,189
|
|
|
2,011,287
|
|
||
|
Property, plant and equipment, net
|
|
3,004,067
|
|
|
2,757,557
|
|
||
|
Equity investments
|
|
9,208
|
|
|
61,305
|
|
||
|
Other assets, net
|
|
|
|
|
||||
|
Intangible assets, net
|
|
213,404
|
|
|
218,431
|
|
||
|
Deferred charges and other assets, net
|
|
173,384
|
|
|
165,410
|
|
||
|
Total other assets, net
|
|
386,788
|
|
|
383,841
|
|
||
|
Total assets
|
|
$
|
5,575,252
|
|
|
$
|
5,213,990
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
|
Current liabilities
|
|
|
|
|
||||
|
Accounts and notes payable
|
|
$
|
235,329
|
|
|
$
|
261,062
|
|
|
Accrued liabilities
|
|
287,313
|
|
|
276,118
|
|
||
|
Total current liabilities
|
|
522,642
|
|
|
537,180
|
|
||
|
Long-term debt
|
|
764,115
|
|
|
763,997
|
|
||
|
Deferred income taxes
|
|
575,603
|
|
|
536,066
|
|
||
|
Other liabilities
|
|
150,961
|
|
|
174,859
|
|
||
|
Total liabilities
|
|
2,013,321
|
|
|
2,012,102
|
|
||
|
Commitments and contingencies (Notes 8 and 22)
|
|
|
|
|
|
|
||
|
Stockholders' equity
|
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares
issued and outstanding
|
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,663,244 and
134,679,064 shares issued at December 31, 2015 and 2014, respectively (Note 9)
|
|
1,347
|
|
|
1,347
|
|
||
|
Common stock, held in treasury, at cost; 4,444,898 and 1,787,546 shares
at December 31, 2015 and 2014, respectively (Note 9)
|
|
(258,312
|
)
|
|
(96,372
|
)
|
||
|
Additional paid-in capital
|
|
542,148
|
|
|
530,441
|
|
||
|
Retained earnings
|
|
3,109,987
|
|
|
2,555,528
|
|
||
|
Accumulated other comprehensive loss
|
|
(129,292
|
)
|
|
(79,433
|
)
|
||
|
Total Westlake Chemical Corporation stockholders' equity
|
|
3,265,878
|
|
|
2,911,511
|
|
||
|
Noncontrolling interests
|
|
296,053
|
|
|
290,377
|
|
||
|
Total equity
|
|
3,561,931
|
|
|
3,201,888
|
|
||
|
Total liabilities and equity
|
|
$
|
5,575,252
|
|
|
$
|
5,213,990
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
(in thousands of dollars,
except share amounts and per share data)
|
||||||||||
|
Net sales
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
Cost of sales
|
|
3,278,145
|
|
|
3,098,000
|
|
|
2,658,046
|
|
|||
|
Gross profit
|
|
1,185,191
|
|
|
1,317,350
|
|
|
1,101,438
|
|
|||
|
Selling, general and administrative expenses
|
|
225,364
|
|
|
193,359
|
|
|
147,974
|
|
|||
|
Income from operations
|
|
959,827
|
|
|
1,123,991
|
|
|
953,464
|
|
|||
|
Other income (expense)
|
|
|
|
|
|
|
||||||
|
Interest expense
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|||
|
Other income (expense), net
|
|
38,270
|
|
|
(2,721
|
)
|
|
6,790
|
|
|||
|
Income before income taxes
|
|
963,441
|
|
|
1,083,918
|
|
|
942,172
|
|
|||
|
Provision for income taxes
|
|
298,396
|
|
|
398,902
|
|
|
331,747
|
|
|||
|
Net income
|
|
665,045
|
|
|
685,016
|
|
|
610,425
|
|
|||
|
Net income attributable to noncontrolling interests
|
|
19,035
|
|
|
6,493
|
|
|
—
|
|
|||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
|
$
|
610,425
|
|
|
Earnings per common share attributable to
Westlake Chemical Corporation (Note 9):
|
|
|
|
|
|
|
||||||
|
Basic
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
|
$
|
4.57
|
|
|
Diluted
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
|
|
|
|
|
|
|
|
||||||
|
Weighted average shares outstanding (Note 9)
|
|
|
|
|
|
|
||||||
|
Basic
|
|
131,823,707
|
|
|
133,111,230
|
|
|
133,224,256
|
|
|||
|
Diluted
|
|
132,301,812
|
|
|
133,643,414
|
|
|
133,779,250
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Dividends per common share (Note 9)
|
|
$
|
0.6930
|
|
|
$
|
0.5820
|
|
|
$
|
0.4125
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
(in thousands of dollars)
|
||||||||||
|
Net income
|
|
$
|
665,045
|
|
|
$
|
685,016
|
|
|
$
|
610,425
|
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
||||||
|
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
||||||
|
Pension and other post-retirement reserves adjustment
(excluding amortization)
|
|
18,260
|
|
|
(25,766
|
)
|
|
12,969
|
|
|||
|
Settlement benefits
|
|
355
|
|
|
—
|
|
|
—
|
|
|||
|
Amortization of benefits liability
|
|
2,663
|
|
|
924
|
|
|
2,712
|
|
|||
|
Income tax (provision) benefit on pension and other
post-retirement benefits liability
|
|
(6,443
|
)
|
|
8,096
|
|
|
(6,026
|
)
|
|||
|
Foreign currency translation adjustments
|
|
(59,466
|
)
|
|
(60,128
|
)
|
|
(1,607
|
)
|
|||
|
Available-for-sale investments
|
|
|
|
|
|
|
||||||
|
Unrealized holding (losses) gains on investments
|
|
(4,362
|
)
|
|
1,301
|
|
|
256
|
|
|||
|
Reclassification of net realized (gains) losses to net income
|
|
(3,798
|
)
|
|
(1,212
|
)
|
|
19
|
|
|||
|
Income tax benefit (provision) on available-for-sale investments
|
|
2,932
|
|
|
(32
|
)
|
|
(99
|
)
|
|||
|
Other comprehensive (loss) income
|
|
(49,859
|
)
|
|
(76,817
|
)
|
|
8,224
|
|
|||
|
Comprehensive income
|
|
615,186
|
|
|
608,199
|
|
|
618,649
|
|
|||
|
Comprehensive income attributable to noncontrolling interests,
net of tax
|
|
19,035
|
|
|
6,493
|
|
|
—
|
|
|||
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
596,151
|
|
|
$
|
601,706
|
|
|
$
|
618,649
|
|
|
|
|
Common Stock
|
|
Common Stock,
Held in Treasury
|
|
|
|
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
|
|
|
||||||||||||||||||||||||||||
|
|
|
Number of
Shares
|
|
Amount
|
|
Number of
Shares
|
|
At Cost
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net
Unrealized
Holding
Gains on
Investments,
Net of Tax
|
|
Noncontrolling Interests
|
|
Total
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
(in thousands of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||||||||||
|
Balances at December 31, 2012
|
|
134,374,448
|
|
|
$
|
1,344
|
|
|
568,986
|
|
|
$
|
(13,302
|
)
|
|
$
|
495,582
|
|
|
$
|
1,399,472
|
|
|
$
|
(16,351
|
)
|
|
$
|
5,511
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,872,256
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
610,425
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
610,425
|
|
|||||||||
|
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,655
|
|
|
(1,607
|
)
|
|
176
|
|
|
—
|
|
|
8,224
|
|
|||||||||
|
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
683,936
|
|
|
(32,918
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32,918
|
)
|
|||||||||
|
Shares issued—stock-
based compensation
|
|
205,760
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
3,435
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,437
|
|
|||||||||
|
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,415
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,415
|
|
|||||||||
|
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,236
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,236
|
)
|
|||||||||
|
Balances at December 31, 2013
|
|
134,580,208
|
|
|
1,346
|
|
|
1,252,922
|
|
|
(46,220
|
)
|
|
511,432
|
|
|
1,954,661
|
|
|
(6,696
|
)
|
|
3,904
|
|
|
176
|
|
|
—
|
|
|
2,418,603
|
|
|||||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
678,523
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,493
|
|
|
685,016
|
|
|||||||||
|
Other comprehensive
(loss) income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,746
|
)
|
|
(60,128
|
)
|
|
57
|
|
|
—
|
|
|
(76,817
|
)
|
|||||||||
|
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
671,791
|
|
|
(52,630
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,630
|
)
|
|||||||||
|
Shares issued—stock-
based compensation
|
|
98,856
|
|
|
1
|
|
|
(137,167
|
)
|
|
2,478
|
|
|
3,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,524
|
|
|||||||||
|
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,964
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,964
|
|
|||||||||
|
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(77,656
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(77,656
|
)
|
|||||||||
|
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,204
|
)
|
|
(2,204
|
)
|
|||||||||
|
Issuance of Westlake
Chemical Partners LP
common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
286,088
|
|
|||||||||
|
Balances at December 31, 2014
|
|
134,679,064
|
|
|
1,347
|
|
|
1,787,546
|
|
|
(96,372
|
)
|
|
530,441
|
|
|
2,555,528
|
|
|
(23,442
|
)
|
|
(56,224
|
)
|
|
233
|
|
|
290,377
|
|
|
3,201,888
|
|
|||||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
646,010
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,035
|
|
|
665,045
|
|
|||||||||
|
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,835
|
|
|
(59,466
|
)
|
|
(5,228
|
)
|
|
—
|
|
|
(49,859
|
)
|
|||||||||
|
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
2,701,937
|
|
|
(163,138
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(163,138
|
)
|
|||||||||
|
Shares issued—stock-
based compensation
|
|
(15,820
|
)
|
|
—
|
|
|
(44,585
|
)
|
|
1,198
|
|
|
(135
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,063
|
|
|||||||||
|
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,842
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,842
|
|
|||||||||
|
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
|||||||||
|
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,956
|
)
|
|
(14,956
|
)
|
|||||||||
|
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,597
|
|
|
1,597
|
|
|||||||||
|
Balances at December 31, 2015
|
|
134,663,244
|
|
|
$
|
1,347
|
|
|
4,444,898
|
|
|
$
|
(258,312
|
)
|
|
$
|
542,148
|
|
|
$
|
3,109,987
|
|
|
$
|
(8,607
|
)
|
|
$
|
(115,690
|
)
|
|
$
|
(4,995
|
)
|
|
$
|
296,053
|
|
|
$
|
3,561,931
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
(in thousands of dollars)
|
||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
|
Net income
|
|
$
|
665,045
|
|
|
$
|
685,016
|
|
|
$
|
610,425
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities
|
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
|
245,757
|
|
|
208,486
|
|
|
157,808
|
|
|||
|
Provision for doubtful accounts
|
|
956
|
|
|
301
|
|
|
5,514
|
|
|||
|
Amortization of debt issuance costs
|
|
2,004
|
|
|
1,673
|
|
|
1,459
|
|
|||
|
Stock-based compensation expense
|
|
10,196
|
|
|
9,261
|
|
|
6,966
|
|
|||
|
Loss from disposition of fixed assets
|
|
10,891
|
|
|
4,181
|
|
|
5,039
|
|
|||
|
(Gains) losses from sales of securities
|
|
(3,798
|
)
|
|
(1,212
|
)
|
|
19
|
|
|||
|
Gain on acquisition, net of loss on the fair value remeasurement
of preexisting equity interest
|
|
(21,045
|
)
|
|
—
|
|
|
—
|
|
|||
|
Impairment of equity method investments
|
|
4,925
|
|
|
6,747
|
|
|
—
|
|
|||
|
Deferred income taxes
|
|
39,784
|
|
|
58,967
|
|
|
93,732
|
|
|||
|
Windfall tax benefits from share-based payment arrangements
|
|
(1,646
|
)
|
|
(6,704
|
)
|
|
(5,449
|
)
|
|||
|
(Income) loss from equity method investments, net of dividends
|
|
(632
|
)
|
|
(424
|
)
|
|
199
|
|
|||
|
Other losses, net
|
|
362
|
|
|
1,487
|
|
|
372
|
|
|||
|
Changes in operating assets and liabilities
|
|
|
|
|
|
|
||||||
|
Accounts receivable
|
|
62,722
|
|
|
33,161
|
|
|
(14,830
|
)
|
|||
|
Inventories
|
|
99,430
|
|
|
51,087
|
|
|
(46,633
|
)
|
|||
|
Prepaid expenses and other current assets
|
|
(4,257
|
)
|
|
7,461
|
|
|
(475
|
)
|
|||
|
Accounts payable
|
|
(21,604
|
)
|
|
(97,237
|
)
|
|
13,820
|
|
|||
|
Accrued liabilities
|
|
(7,640
|
)
|
|
74,989
|
|
|
(15,147
|
)
|
|||
|
Other, net
|
|
(2,614
|
)
|
|
(4,864
|
)
|
|
(60,090
|
)
|
|||
|
Net cash provided by operating activities
|
|
1,078,836
|
|
|
1,032,376
|
|
|
752,729
|
|
|||
|
Cash flows from investing activities
|
|
|
|
|
|
|
||||||
|
Acquisition of business, net of cash acquired
|
|
15,782
|
|
|
(611,087
|
)
|
|
(178,309
|
)
|
|||
|
Additions to equity investments
|
|
—
|
|
|
—
|
|
|
(23,338
|
)
|
|||
|
Additions to property, plant and equipment
|
|
(491,426
|
)
|
|
(431,104
|
)
|
|
(679,222
|
)
|
|||
|
Construction of assets pending sale-leaseback
|
|
—
|
|
|
—
|
|
|
(136
|
)
|
|||
|
Proceeds from disposition of assets
|
|
49
|
|
|
181
|
|
|
151
|
|
|||
|
Proceeds from disposition of equity method investment
|
|
27,865
|
|
|
—
|
|
|
—
|
|
|||
|
Proceeds from repayment of loan acquired
|
|
—
|
|
|
45,923
|
|
|
—
|
|
|||
|
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
—
|
|
|
167
|
|
|||
|
Proceeds from sales and maturities of securities
|
|
48,900
|
|
|
342,045
|
|
|
252,519
|
|
|||
|
Purchase of securities
|
|
(605,098
|
)
|
|
(117,332
|
)
|
|
(367,150
|
)
|
|||
|
Settlements of derivative instruments
|
|
(2,248
|
)
|
|
(1,831
|
)
|
|
(6,920
|
)
|
|||
|
Net cash used for investing activities
|
|
(1,006,176
|
)
|
|
(773,205
|
)
|
|
(1,002,238
|
)
|
|||
|
Cash flows from financing activities
|
|
|
|
|
|
|
||||||
|
Capitalized debt issuance costs
|
|
—
|
|
|
(1,186
|
)
|
|
—
|
|
|||
|
Dividends paid
|
|
(91,551
|
)
|
|
(77,656
|
)
|
|
(55,236
|
)
|
|||
|
Distributions to noncontrolling interests
|
|
(14,856
|
)
|
|
(2,204
|
)
|
|
—
|
|
|||
|
Net proceeds from issuance of Westlake Chemical Partners LP
common units
|
|
—
|
|
|
286,088
|
|
|
—
|
|
|||
|
Proceeds from exercise of stock options
|
|
1,063
|
|
|
5,524
|
|
|
3,437
|
|
|||
|
Proceeds from issuance of notes payable
|
|
52,960
|
|
|
—
|
|
|
—
|
|
|||
|
Repayment of notes payable
|
|
(73,615
|
)
|
|
—
|
|
|
—
|
|
|||
|
Repurchase of common stock for treasury
|
|
(162,459
|
)
|
|
(52,630
|
)
|
|
(32,918
|
)
|
|||
|
Windfall tax benefits from share-based payment arrangements
|
|
1,646
|
|
|
6,704
|
|
|
5,449
|
|
|||
|
Net cash (used for) provided by financing activities
|
|
(286,812
|
)
|
|
164,640
|
|
|
(79,268
|
)
|
|||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(3,924
|
)
|
|
(4,511
|
)
|
|
—
|
|
|||
|
Net (decrease) increase in cash and cash equivalents
|
|
(218,076
|
)
|
|
419,300
|
|
|
(328,777
|
)
|
|||
|
Cash and cash equivalents at beginning of the year
|
|
880,601
|
|
|
461,301
|
|
|
790,078
|
|
|||
|
Cash and cash equivalents at end of the year
|
|
$
|
662,525
|
|
|
$
|
880,601
|
|
|
$
|
461,301
|
|
|
Classification
|
|
Years
|
|
|
|
|
|
Buildings and improvements
|
25
|
|
|
Plant and equipment
|
25
|
|
|
Ethylene pipeline
|
35
|
|
|
Other
|
3-10
|
|
|
|
2015
|
|
2014
|
||||
|
Current
|
$
|
520,144
|
|
|
$
|
—
|
|
|
Non-current
|
48,081
|
|
|
15,414
|
|
||
|
Total available-for-sale securities
|
$
|
568,225
|
|
|
$
|
15,414
|
|
|
|
|
December 31, 2015
|
||||||||||||||
|
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
|
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
|
Corporate bonds
|
|
$
|
336,665
|
|
|
$
|
55
|
|
|
$
|
(1,076
|
)
|
|
$
|
335,644
|
|
|
U.S. government debt
(2)
|
|
135,226
|
|
|
2
|
|
|
(374
|
)
|
|
134,854
|
|
||||
|
Asset-backed securities
|
|
49,759
|
|
|
2
|
|
|
(115
|
)
|
|
49,646
|
|
||||
|
Equity securities
|
|
54,371
|
|
|
466
|
|
|
(6,756
|
)
|
|
48,081
|
|
||||
|
Total available-for-sale securities
|
|
$
|
576,021
|
|
|
$
|
525
|
|
|
$
|
(8,321
|
)
|
|
$
|
568,225
|
|
|
|
|
December 31, 2014
|
||||||||||||||
|
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair Value
|
||||||||
|
Equity securities
|
|
$
|
15,050
|
|
|
$
|
364
|
|
|
$
|
—
|
|
|
$
|
15,414
|
|
|
Total available-for-sale securities
|
|
$
|
15,050
|
|
|
$
|
364
|
|
|
$
|
—
|
|
|
$
|
15,414
|
|
|
(1)
|
All unrealized loss positions were held at a loss for less than 12 months.
|
|
(2)
|
U.S. Treasury obligations, U.S. government agency obligations and U.S government agency mortgage-backed securities.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Proceeds from sales and maturities of securities
|
|
$
|
48,900
|
|
|
$
|
342,045
|
|
|
$
|
7,770
|
|
|
Gross realized gains
|
|
3,830
|
|
|
1,311
|
|
|
20
|
|
|||
|
Gross realized losses
|
|
(32
|
)
|
|
(99
|
)
|
|
(39
|
)
|
|||
|
|
|
2015
|
|
2014
|
||||
|
Trade customers
|
|
$
|
438,538
|
|
|
$
|
525,546
|
|
|
Affiliates
|
|
—
|
|
|
437
|
|
||
|
Allowance for doubtful accounts
|
|
(14,095
|
)
|
|
(13,468
|
)
|
||
|
|
|
424,443
|
|
|
512,515
|
|
||
|
Federal and state taxes
|
|
60,748
|
|
|
8,919
|
|
||
|
Other
|
|
23,341
|
|
|
39,232
|
|
||
|
Accounts receivable, net
|
|
$
|
508,532
|
|
|
$
|
560,666
|
|
|
|
|
2015
|
|
2014
|
||||
|
Finished products
|
|
$
|
253,338
|
|
|
$
|
300,909
|
|
|
Feedstock, additives and chemicals
|
|
106,435
|
|
|
158,635
|
|
||
|
Materials and supplies
|
|
74,287
|
|
|
66,232
|
|
||
|
Inventories
|
|
$
|
434,060
|
|
|
$
|
525,776
|
|
|
|
|
2015
|
|
2014
|
||||
|
Land
|
|
$
|
33,051
|
|
|
$
|
21,211
|
|
|
Building and improvements
|
|
266,214
|
|
|
244,101
|
|
||
|
Plant and equipment
|
|
3,632,416
|
|
|
3,454,462
|
|
||
|
Other
|
|
241,829
|
|
|
213,707
|
|
||
|
|
|
4,173,510
|
|
|
3,933,481
|
|
||
|
Less: Accumulated depreciation
|
|
(1,685,255
|
)
|
|
(1,531,331
|
)
|
||
|
|
|
2,488,255
|
|
|
2,402,150
|
|
||
|
Construction in progress
|
|
515,812
|
|
|
355,407
|
|
||
|
Property, plant and equipment, net
|
|
$
|
3,004,067
|
|
|
$
|
2,757,557
|
|
|
|
|
2015
|
|
2014
|
|
Weighted
Average
Life
|
||||||||||||||||||||
|
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
|||||||||||||
|
Intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Licenses and intellectual
property
|
|
$
|
79,699
|
|
|
$
|
(38,643
|
)
|
|
$
|
41,056
|
|
|
$
|
82,611
|
|
|
$
|
(35,732
|
)
|
|
$
|
46,879
|
|
|
15
|
|
Trademarks
|
|
39,085
|
|
|
(2,602
|
)
|
|
36,483
|
|
|
42,790
|
|
|
(759
|
)
|
|
42,031
|
|
|
20
|
||||||
|
Customer relationships
|
|
75,249
|
|
|
(22,572
|
)
|
|
52,677
|
|
|
75,249
|
|
|
(17,374
|
)
|
|
57,875
|
|
|
14
|
||||||
|
Goodwill
|
|
62,016
|
|
|
—
|
|
|
62,016
|
|
|
62,016
|
|
|
—
|
|
|
62,016
|
|
|
|
||||||
|
Other
|
|
29,320
|
|
|
(8,148
|
)
|
|
21,172
|
|
|
16,501
|
|
|
(6,871
|
)
|
|
9,630
|
|
|
7
|
||||||
|
Total intangible assets
|
|
285,369
|
|
|
(71,965
|
)
|
|
213,404
|
|
|
279,167
|
|
|
(60,736
|
)
|
|
218,431
|
|
|
|
||||||
|
Available-for-sale investments
|
|
48,081
|
|
|
—
|
|
|
48,081
|
|
|
15,414
|
|
|
—
|
|
|
15,414
|
|
|
|
||||||
|
Cost-method investments
|
|
51,334
|
|
|
—
|
|
|
51,334
|
|
|
57,147
|
|
|
—
|
|
|
57,147
|
|
|
|
||||||
|
Turnaround costs
|
|
111,078
|
|
|
(74,943
|
)
|
|
36,135
|
|
|
107,892
|
|
|
(56,493
|
)
|
|
51,399
|
|
|
5
|
||||||
|
Debt issuance costs
|
|
20,406
|
|
|
(13,286
|
)
|
|
7,120
|
|
|
20,406
|
|
|
(11,282
|
)
|
|
9,124
|
|
|
13
|
||||||
|
Other
|
|
51,682
|
|
|
(20,968
|
)
|
|
30,714
|
|
|
50,571
|
|
|
(18,245
|
)
|
|
32,326
|
|
|
3
|
||||||
|
Total deferred charges and
other assets
|
|
282,581
|
|
|
(109,197
|
)
|
|
173,384
|
|
|
251,430
|
|
|
(86,020
|
)
|
|
165,410
|
|
|
|
||||||
|
Other assets, net
|
|
$
|
567,950
|
|
|
$
|
(181,162
|
)
|
|
$
|
386,788
|
|
|
$
|
530,597
|
|
|
$
|
(146,756
|
)
|
|
$
|
383,841
|
|
|
|
|
|
|
Olefins Segment
|
|
Vinyls Segment
|
|
Total
|
||||||
|
Balance at December 31, 2013
|
|
$
|
29,990
|
|
|
$
|
32,026
|
|
|
$
|
62,016
|
|
|
Goodwill acquired during the year
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Balance at December 31, 2014
|
|
29,990
|
|
|
32,026
|
|
|
62,016
|
|
|||
|
Changes in goodwill during the year
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Balance at December 31, 2015
|
|
$
|
29,990
|
|
|
$
|
32,026
|
|
|
$
|
62,016
|
|
|
|
|
2015
|
|
2014
|
||||
|
Accounts payable
|
|
$
|
229,219
|
|
|
$
|
261,062
|
|
|
Notes payable to banks
|
|
6,110
|
|
|
—
|
|
||
|
Accounts and notes payable
|
|
$
|
235,329
|
|
|
$
|
261,062
|
|
|
|
|
2015
|
|
2014
|
||||
|
3.60% senior notes due 2022
|
|
$
|
249,226
|
|
|
$
|
249,108
|
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
100,000
|
|
||
|
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
250,000
|
|
||
|
6 ½% senior notes due 2035 (the "6 ½% GO Zone Senior Notes Due 2035")
|
|
89,000
|
|
|
89,000
|
|
||
|
6 ½% senior notes due 2035 (the "6 ½% IKE Zone Senior Notes Due 2035")
|
|
65,000
|
|
|
65,000
|
|
||
|
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
||
|
Long-term debt, net
|
|
$
|
764,115
|
|
|
$
|
763,997
|
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
|
Balances at December 31, 2013
|
|
$
|
(6,696
|
)
|
|
$
|
3,904
|
|
|
$
|
176
|
|
|
$
|
(2,616
|
)
|
|
Other comprehensive (loss) income before
reclassifications
|
|
(17,314
|
)
|
|
(60,128
|
)
|
|
834
|
|
|
(76,608
|
)
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss
|
|
568
|
|
|
—
|
|
|
(777
|
)
|
|
(209
|
)
|
||||
|
Net other comprehensive (loss) income for the year
|
|
(16,746
|
)
|
|
(60,128
|
)
|
|
57
|
|
|
(76,817
|
)
|
||||
|
Balances at December 31, 2014
|
|
(23,442
|
)
|
|
(56,224
|
)
|
|
233
|
|
|
(79,433
|
)
|
||||
|
Other comprehensive income (loss) before
reclassifications
|
|
12,877
|
|
|
(59,466
|
)
|
|
(2,795
|
)
|
|
(49,384
|
)
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss
|
|
1,958
|
|
|
—
|
|
|
(2,433
|
)
|
|
(475
|
)
|
||||
|
Net other comprehensive income (loss) for the year
|
|
14,835
|
|
|
(59,466
|
)
|
|
(5,228
|
)
|
|
(49,859
|
)
|
||||
|
Balances at December 31, 2015
|
|
$
|
(8,607
|
)
|
|
$
|
(115,690
|
)
|
|
$
|
(4,995
|
)
|
|
$
|
(129,292
|
)
|
|
Details about Accumulated Other
Comprehensive Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Year Ended December 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|||||||||
|
Amortization of pension and other
post-retirement items
|
|
|
|
|
|
|
|
|
||||||
|
Prior service costs
|
|
(1)
|
|
$
|
—
|
|
|
$
|
(347
|
)
|
|
$
|
(381
|
)
|
|
Net loss
|
|
(1)
|
|
(2,663
|
)
|
|
(577
|
)
|
|
(2,331
|
)
|
|||
|
Settlement benefits
|
|
(1)
|
|
(355
|
)
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
(3,018
|
)
|
|
(924
|
)
|
|
(2,712
|
)
|
|||
|
|
|
Provision for income taxes
|
|
1,060
|
|
|
356
|
|
|
1,043
|
|
|||
|
|
|
|
|
(1,958
|
)
|
|
(568
|
)
|
|
(1,669
|
)
|
|||
|
Net unrealized gains on available-for-
sale investments
|
|
|
|
|
|
|
|
|
||||||
|
Realized gain (loss) on available-
for-sale investments
|
|
Other income (expense), net
|
|
3,798
|
|
|
1,212
|
|
|
(19
|
)
|
|||
|
|
|
Provision for income taxes
|
|
(1,365
|
)
|
|
(435
|
)
|
|
7
|
|
|||
|
|
|
|
|
2,433
|
|
|
777
|
|
|
(12
|
)
|
|||
|
Total reclassifications for the period
|
|
|
|
$
|
475
|
|
|
$
|
209
|
|
|
$
|
(1,681
|
)
|
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, see Note 11.
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
|
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
|
Benefit obligation, beginning of year
|
|
$
|
67,010
|
|
|
$
|
122,701
|
|
|
$
|
57,946
|
|
|
$
|
—
|
|
|
Benefit obligation assumed with acquisition
|
|
—
|
|
|
—
|
|
|
—
|
|
|
117,970
|
|
||||
|
Service cost
|
|
29
|
|
|
1,661
|
|
|
334
|
|
|
602
|
|
||||
|
Interest cost
|
|
2,015
|
|
|
2,110
|
|
|
2,322
|
|
|
1,366
|
|
||||
|
Actuarial (gain) loss
|
|
(2,330
|
)
|
|
(17,310
|
)
|
|
9,165
|
|
|
15,425
|
|
||||
|
Benefits paid
|
|
(4,532
|
)
|
|
(2,139
|
)
|
|
(2,757
|
)
|
|
(898
|
)
|
||||
|
Foreign exchange effects
|
|
—
|
|
|
(12,202
|
)
|
|
—
|
|
|
(11,764
|
)
|
||||
|
Benefit obligation, end of year
|
|
$
|
62,192
|
|
|
$
|
94,821
|
|
|
$
|
67,010
|
|
|
$
|
122,701
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
|
Fair value of plan assets, beginning of year
|
|
$
|
53,415
|
|
|
$
|
—
|
|
|
$
|
49,236
|
|
|
$
|
—
|
|
|
Actual return
|
|
(268
|
)
|
|
—
|
|
|
2,953
|
|
|
—
|
|
||||
|
Employer contribution
|
|
2,148
|
|
|
2,139
|
|
|
3,983
|
|
|
898
|
|
||||
|
Benefits paid
|
|
(4,532
|
)
|
|
(2,139
|
)
|
|
(2,757
|
)
|
|
(898
|
)
|
||||
|
Fair value of plan assets, end of year
|
|
$
|
50,763
|
|
|
$
|
—
|
|
|
$
|
53,415
|
|
|
$
|
—
|
|
|
Funded status, end of year
|
|
$
|
(11,429
|
)
|
|
$
|
(94,821
|
)
|
|
$
|
(13,595
|
)
|
|
$
|
(122,701
|
)
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
|
Amounts recognized in the consolidated
balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
|
Noncurrent liabilities
|
|
$
|
(11,429
|
)
|
|
$
|
(94,821
|
)
|
|
$
|
(13,595
|
)
|
|
$
|
(122,701
|
)
|
|
Net amount recognized
|
|
$
|
(11,429
|
)
|
|
$
|
(94,821
|
)
|
|
$
|
(13,595
|
)
|
|
$
|
(122,701
|
)
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
|
Amounts recognized in accumulated other
comprehensive income
|
|
|
|
|
|
|
|
|
||||||||
|
Net loss (gain)
|
|
$
|
14,755
|
|
|
$
|
(4,919
|
)
|
|
$
|
15,482
|
|
|
$
|
15,425
|
|
|
Foreign exchange effects
|
|
—
|
|
|
1,986
|
|
|
—
|
|
|
—
|
|
||||
|
Total before tax
(1)
|
|
$
|
14,755
|
|
|
$
|
(2,933
|
)
|
|
$
|
15,482
|
|
|
$
|
15,425
|
|
|
(1)
|
After-tax totals for pension benefits were
$6,812
and
$20,315
for
2015
and
2014
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive loss.
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
Information for pension plans with an accumulated
benefit obligation in excess of plan assets
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
|
Projected benefit obligation
|
|
$
|
(62,192
|
)
|
|
$
|
(94,821
|
)
|
|
$
|
(67,010
|
)
|
|
$
|
(122,701
|
)
|
|
Accumulated benefit obligation
|
|
(62,192
|
)
|
|
(93,231
|
)
|
|
(67,010
|
)
|
|
(119,258
|
)
|
||||
|
Fair value of plan assets
|
|
50,763
|
|
|
—
|
|
|
53,415
|
|
|
—
|
|
||||
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||||||||||
|
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
||||||||||
|
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Service cost
|
|
$
|
29
|
|
|
$
|
1,661
|
|
|
$
|
334
|
|
|
$
|
602
|
|
|
$
|
1,091
|
|
|
Interest cost
|
|
2,015
|
|
|
2,110
|
|
|
2,322
|
|
|
1,366
|
|
|
2,047
|
|
|||||
|
Expected return on plan assets
|
|
(2,960
|
)
|
|
—
|
|
|
(3,140
|
)
|
|
—
|
|
|
(2,854
|
)
|
|||||
|
Net amortization
|
|
1,270
|
|
|
1,048
|
|
|
571
|
|
|
—
|
|
|
2,255
|
|
|||||
|
Settlement benefits
|
|
355
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Net periodic benefit cost
|
|
$
|
709
|
|
|
$
|
4,819
|
|
|
$
|
87
|
|
|
$
|
1,968
|
|
|
$
|
2,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Other changes in plan assets and benefit obligation
recognized in other comprehensive income (OCI)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net loss (gain) emerging
|
|
$
|
898
|
|
|
$
|
(17,310
|
)
|
|
$
|
9,352
|
|
|
$
|
15,425
|
|
|
$
|
(12,468
|
)
|
|
Amortization of net loss
|
|
(1,270
|
)
|
|
(1,048
|
)
|
|
(274
|
)
|
|
—
|
|
|
(1,958
|
)
|
|||||
|
Amortization of prior service cost
|
|
—
|
|
|
—
|
|
|
(297
|
)
|
|
—
|
|
|
(297
|
)
|
|||||
|
Settlement benefits
|
|
(355
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total recognized in OCI
|
|
$
|
(727
|
)
|
|
$
|
(18,358
|
)
|
|
$
|
8,781
|
|
|
$
|
15,425
|
|
|
$
|
(14,723
|
)
|
|
Total net periodic benefit cost and OCI
|
|
$
|
(18
|
)
|
|
$
|
(13,539
|
)
|
|
$
|
8,868
|
|
|
$
|
17,393
|
|
|
$
|
(12,184
|
)
|
|
|
|
2015
|
|
2014
|
|
2013
|
|||||||||
|
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|||||
|
Weighted average assumptions used to determine
benefit obligations at December 31
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Discount rate
|
|
4.0
|
%
|
|
2.4
|
%
|
|
3.5
|
%
|
|
1.9
|
%
|
|
4.5
|
%
|
|
Expected return on plan assets
|
|
7.0
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
Rate of compensation increase
|
|
—
|
%
|
|
2.5
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
4.0
|
%
|
|
Weighted average assumptions used to
determine net periodic benefit costs for
years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Discount rate
|
|
3.5
|
%
|
|
1.9
|
%
|
|
4.5
|
%
|
|
2.6
|
%
|
|
3.3
|
%
|
|
Expected return on plan assets
|
|
7.0
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
Rate of compensation increase
|
|
—
|
%
|
|
2.5
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
4.0
|
%
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
||||||||||||
|
|
|
Level 2
|
|
Total
|
|
Level 2
|
|
Total
|
||||||||
|
Bank collective trust funds—Equity securities:
|
|
|
|
|
|
|
|
|
||||||||
|
Large-cap index funds
(1)
|
|
$
|
18,384
|
|
|
$
|
18,384
|
|
|
$
|
19,473
|
|
|
$
|
19,473
|
|
|
Small-cap index funds
(2)
|
|
4,069
|
|
|
4,069
|
|
|
3,351
|
|
|
3,351
|
|
||||
|
International index funds
(3)
|
|
8,181
|
|
|
8,181
|
|
|
8,474
|
|
|
8,474
|
|
||||
|
Bank collective trust funds—Fixed income:
|
|
|
|
|
|
|
|
|
||||||||
|
Bond index funds
(4)
|
|
19,624
|
|
|
19,624
|
|
|
21,495
|
|
|
21,495
|
|
||||
|
Short term investment funds
|
|
505
|
|
|
505
|
|
|
622
|
|
|
622
|
|
||||
|
|
|
$
|
50,763
|
|
|
$
|
50,763
|
|
|
$
|
53,415
|
|
|
$
|
53,415
|
|
|
(1)
|
Substantially all of the assets of these funds are invested in large-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
|
(2)
|
Substantially all of the assets of these funds are invested in small-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
|
(3)
|
Substantially all of the assets of these funds are invested in international companies in developed markets (excluding the United States and Canada). The remainder of the assets of these funds is invested in cash reserves.
|
|
(4)
|
This category represents investment grade bonds of U.S. issuers, including U.S. Treasury notes.
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
||||
|
Contributions to multi-employer plans
(1)
|
|
$
|
4,489
|
|
|
$
|
2,295
|
|
|
(1)
|
The plan information for both the Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG plans is publicly available. The plans provide fixed, monthly retirement payments on the basis of the credits earned by the participating employees. To the extent that the plans are underfunded, future contributions to the plans may increase and may be used to fund retirement benefits for employees related to other employers. The Company does not consider either of its multi-employer plans individually significant.
|
|
|
|
2015
|
|
2014
|
||||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
||||
|
Change in benefit obligation
|
|
|
|
|
||||
|
Benefit obligation, beginning of year
|
|
$
|
20,177
|
|
|
$
|
19,958
|
|
|
Service cost
|
|
22
|
|
|
22
|
|
||
|
Interest cost
|
|
571
|
|
|
733
|
|
||
|
Actuarial (gain) loss
|
|
(1,848
|
)
|
|
989
|
|
||
|
Benefits paid
|
|
(1,107
|
)
|
|
(1,525
|
)
|
||
|
Benefit obligation, end of year
|
|
$
|
17,815
|
|
|
$
|
20,177
|
|
|
|
|
|
|
|
||||
|
Change in plan assets
|
|
|
|
|
||||
|
Fair value of plan assets, beginning of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Employer contribution
|
|
1,107
|
|
|
1,525
|
|
||
|
Benefits paid
|
|
(1,107
|
)
|
|
(1,525
|
)
|
||
|
Fair value of plan assets, end of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Funded status, end of year
|
|
$
|
(17,815
|
)
|
|
$
|
(20,177
|
)
|
|
|
|
2015
|
|
2014
|
||||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
||||
|
Amounts recognized in the consolidated balance sheet at December 31
|
|
|
|
|
||||
|
Current liabilities
|
|
$
|
(1,244
|
)
|
|
$
|
(1,798
|
)
|
|
Noncurrent liabilities
|
|
(16,571
|
)
|
|
(18,379
|
)
|
||
|
Net amount recognized
|
|
$
|
(17,815
|
)
|
|
$
|
(20,177
|
)
|
|
|
|
2015
|
|
2014
|
||||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
||||
|
Amounts recognized in accumulated other comprehensive income
|
|
|
|
|
||||
|
Net loss
|
|
$
|
2,978
|
|
|
$
|
5,171
|
|
|
Total before tax
(1)
|
|
$
|
2,978
|
|
|
$
|
5,171
|
|
|
(1)
|
After-tax totals for post-retirement healthcare benefits were
$1,795
and
$3,127
for
2015
and
2014
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive loss.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
||||||
|
Components of net periodic benefit cost
|
|
|
|
|
|
|
||||||
|
Service cost
|
|
$
|
22
|
|
|
$
|
22
|
|
|
$
|
30
|
|
|
Interest cost
|
|
571
|
|
|
733
|
|
|
623
|
|
|||
|
Net amortization
|
|
345
|
|
|
353
|
|
|
457
|
|
|||
|
Net periodic benefit cost
|
|
$
|
938
|
|
|
$
|
1,108
|
|
|
$
|
1,110
|
|
|
|
|
|
|
|
|
|
||||||
|
Other changes in plan assets and benefit obligation recognized in
other comprehensive income (OCI)
|
|
|
|
|
|
|
||||||
|
Net (gain) loss emerging
|
|
$
|
(1,848
|
)
|
|
$
|
989
|
|
|
$
|
(501
|
)
|
|
Amortization of net loss
|
|
(345
|
)
|
|
(303
|
)
|
|
(373
|
)
|
|||
|
Amortization of prior service cost
|
|
—
|
|
|
(50
|
)
|
|
(84
|
)
|
|||
|
Total recognized in OCI
|
|
$
|
(2,193
|
)
|
|
$
|
636
|
|
|
$
|
(958
|
)
|
|
Total net periodic benefit cost and OCI
|
|
$
|
(1,255
|
)
|
|
$
|
1,744
|
|
|
$
|
152
|
|
|
|
|
2015
|
|
2014
|
|
2013
|
|||
|
|
|
U.S. Plans
|
|
U.S. Plans
|
|
U.S. Plans
|
|||
|
Weighted average assumptions used to determine benefit
obligations at December 31
|
|
|
|
|
|
|
|||
|
Discount rate
|
|
3.5
|
%
|
|
3.3
|
%
|
|
4.0
|
%
|
|
Weighted average assumptions used to determine net periodic
benefit costs for years ended December 31
|
|
|
|
|
|
|
|||
|
Discount rate
|
|
3.3
|
%
|
|
4.0
|
%
|
|
3.0
|
%
|
|
|
|
Pension
Benefits
|
|
Post-
retirement
Healthcare
|
||||
|
Estimated future benefit payments:
|
|
|
|
|
||||
|
Year 1
|
|
$
|
8,159
|
|
|
$
|
1,244
|
|
|
Year 2
|
|
7,345
|
|
|
1,408
|
|
||
|
Year 3
|
|
7,901
|
|
|
1,409
|
|
||
|
Year 4
|
|
8,461
|
|
|
1,395
|
|
||
|
Year 5
|
|
7,813
|
|
|
1,363
|
|
||
|
Years 6 to 10
|
|
36,897
|
|
|
6,005
|
|
||
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Term
(Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
Outstanding at December 31, 2014
|
|
1,179,402
|
|
|
$
|
24.89
|
|
|
|
|
|
||
|
Granted
|
|
168,369
|
|
|
67.59
|
|
|
|
|
|
|||
|
Exercised
|
|
(32,308
|
)
|
|
32.92
|
|
|
|
|
|
|||
|
Cancelled
|
|
(47,673
|
)
|
|
32.64
|
|
|
|
|
|
|||
|
Outstanding at December 31, 2015
|
|
1,267,790
|
|
|
$
|
30.07
|
|
|
5.0
|
|
$
|
34,577
|
|
|
Exercisable at December 31, 2015
|
|
822,573
|
|
|
$
|
19.08
|
|
|
4.2
|
|
$
|
29,376
|
|
|
Range of Prices
|
|
Options
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
|
$7.12 - $9.65
|
|
304,200
|
|
|
2.7
|
|
$10.26 - $18.05
|
|
349,906
|
|
|
2.6
|
|
$22.92 - $30.05
|
|
191,292
|
|
|
5.7
|
|
$40.38 - $52.35
|
|
107,562
|
|
|
7.3
|
|
$63.98 - $68.18
|
|
314,830
|
|
|
8.7
|
|
|
|
Stock Option Grants
|
||||||||||
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Weighted average fair value
|
|
$
|
20.21
|
|
|
$
|
20.49
|
|
|
$
|
17.03
|
|
|
Risk-free interest rate
|
|
1.7
|
%
|
|
1.6
|
%
|
|
0.9
|
%
|
|||
|
Expected life in years
|
|
5
|
|
|
5
|
|
|
5
|
|
|||
|
Expected volatility
|
|
34.2
|
%
|
|
35.7
|
%
|
|
44.5
|
%
|
|||
|
Expected dividend yield
|
|
0.9
|
%
|
|
0.7
|
%
|
|
0.6
|
%
|
|||
|
|
|
Number of
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Non-vested at December 31, 2014
|
|
205,056
|
|
|
$
|
24.52
|
|
|
Vested
|
|
(124,380
|
)
|
|
30.17
|
|
|
|
Forfeited
|
|
(15,820
|
)
|
|
15.81
|
|
|
|
Non-vested at December 31, 2015
|
|
64,856
|
|
|
$
|
15.81
|
|
|
|
|
Number of
Units
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Non-vested at December 31, 2014
|
|
422,000
|
|
|
$
|
55.75
|
|
|
Granted
|
|
100,258
|
|
|
65.77
|
|
|
|
Vested
|
|
(12,277
|
)
|
|
61.08
|
|
|
|
Forfeited
|
|
(11,109
|
)
|
|
56.82
|
|
|
|
Non-vested at December 31, 2015
|
|
498,872
|
|
|
$
|
57.61
|
|
|
|
|
Asset Derivatives
|
||||||||
|
|
|
Balance Sheet Location
|
|
Fair Value as of December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||||
|
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
|
Commodity forward contracts
|
|
Accounts receivable, net
|
|
$
|
3,465
|
|
|
$
|
3,145
|
|
|
Commodity forward contracts
|
|
Deferred charges and
other assets, net
|
|
2,088
|
|
|
—
|
|
||
|
Total asset derivatives
|
|
$
|
5,553
|
|
|
$
|
3,145
|
|
||
|
|
|
|
|
|
|
|
||||
|
|
|
Liability Derivatives
|
||||||||
|
|
|
Balance Sheet Location
|
|
Fair Value as of December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||||
|
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
|
Commodity forward contracts
|
|
Accrued liabilities
|
|
$
|
9,325
|
|
|
$
|
6,549
|
|
|
Commodity forward contracts
|
|
Other liabilities
|
|
12,437
|
|
|
3,559
|
|
||
|
Total liability derivatives
|
|
$
|
21,762
|
|
|
$
|
10,108
|
|
||
|
Derivatives in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in Income on Derivative
|
|
Year Ended December 31,
|
||
|
2013
|
||||||
|
Commodity forward contracts
|
|
Cost of sales
|
|
$
|
(303
|
)
|
|
Hedged Items in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in Income on
Hedged Items
|
|
Year Ended December 31,
|
||
|
2013
|
||||||
|
Firm commitment designated as the hedged item
|
|
Cost of sales
|
|
$
|
143
|
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss)
Recognized in Income on Derivative
|
|
Year Ended December 31,
|
||||||||||
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
Commodity forward contracts
|
|
Gross profit
|
|
$
|
(11,395
|
)
|
|
$
|
(9,678
|
)
|
|
$
|
5,438
|
|
|
|
|
Derivative Assets
as of December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Derivative assets subject to enforceable master netting arrangements
|
|
$
|
—
|
|
|
$
|
2,333
|
|
|
Derivative assets not subject to enforceable master netting arrangements
|
|
462
|
|
|
111
|
|
||
|
Total derivative assets
|
|
$
|
462
|
|
|
$
|
2,444
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Offsetting of Derivative Assets
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts Offset in the Consolidated Balance Sheet
|
|
Net Amounts of Assets Presented in the Consolidated Balance Sheet
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts Offset in the Consolidated Balance Sheet
|
|
Net Amounts of Assets Presented in the Consolidated Balance Sheet
|
||||||||||||
|
Commodity forward contracts
|
|
$
|
5,091
|
|
|
$
|
(5,091
|
)
|
|
$
|
—
|
|
|
$
|
3,034
|
|
|
$
|
(701
|
)
|
|
$
|
2,333
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Derivative Assets by Counterparty
|
|
Net Amounts of Assets Presented in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheet
|
|
Net Amount
|
|
Net Amounts of Assets Presented in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheet
|
|
Net Amount
|
||||||||||||
|
Counterparty A
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,333
|
|
|
$
|
—
|
|
|
$
|
2,333
|
|
|
Total
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,333
|
|
|
$
|
—
|
|
|
$
|
2,333
|
|
|
|
|
Derivative Liabilities
as of December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Derivative liabilities subject to enforceable master netting arrangements
|
|
$
|
5,803
|
|
|
$
|
1,490
|
|
|
Derivative liabilities not subject to enforceable master netting arrangements
|
|
10,868
|
|
|
7,917
|
|
||
|
Total derivative liabilities
|
|
$
|
16,671
|
|
|
$
|
9,407
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Offsetting of Derivative Liabilities
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts Offset in the Consolidated Balance Sheet
|
|
Net Amounts of Liabilities Presented in the Consolidated Balance Sheet
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts Offset in the Consolidated Balance Sheet
|
|
Net Amounts of Liabilities Presented in the Consolidated Balance Sheet
|
||||||||||||
|
Commodity forward contracts
|
|
$
|
10,894
|
|
|
$
|
(5,091
|
)
|
|
$
|
5,803
|
|
|
$
|
2,191
|
|
|
$
|
(701
|
)
|
|
$
|
1,490
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Derivative Liabilities by Counterparty
|
|
Net Amounts of Liabilities Presented in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheet
|
|
Net Amount
|
|
Net Amounts of Liabilities Presented in the Consolidated Balance Sheet
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheet
|
|
Net Amount
|
||||||||||||
|
Counterparty A
|
|
$
|
5,564
|
|
|
$
|
—
|
|
|
$
|
5,564
|
|
|
$
|
1,490
|
|
|
$
|
—
|
|
|
$
|
1,490
|
|
|
Counterparty B
|
|
239
|
|
|
—
|
|
|
239
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
5,803
|
|
|
$
|
—
|
|
|
$
|
5,803
|
|
|
$
|
1,490
|
|
|
$
|
—
|
|
|
$
|
1,490
|
|
|
|
|
2015
|
||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Derivative instruments
|
|
|
|
|
|
|
||||||
|
Risk management assets—Commodity forward contracts
|
|
$
|
5,553
|
|
|
$
|
—
|
|
|
$
|
5,553
|
|
|
Risk management liabilities—Commodity forward contracts
|
|
(11,648
|
)
|
|
(10,114
|
)
|
|
(21,762
|
)
|
|||
|
Marketable securities
|
|
|
|
|
|
|
||||||
|
Available-for-sale securities
|
|
48,081
|
|
|
520,144
|
|
|
568,225
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
|
|
2014
|
||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Derivative instruments
|
|
|
|
|
|
|
||||||
|
Risk management assets—Commodity forward contracts
|
|
$
|
3,143
|
|
|
$
|
2
|
|
|
$
|
3,145
|
|
|
Risk management liabilities—Commodity forward contracts
|
|
—
|
|
|
(10,108
|
)
|
|
(10,108
|
)
|
|||
|
Marketable securities
|
|
|
|
|
|
|
||||||
|
Available-for-sale securities
|
|
15,414
|
|
|
—
|
|
|
15,414
|
|
|||
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
|
3.60% senior notes due 2022
|
|
$
|
249,226
|
|
|
$
|
244,828
|
|
|
$
|
249,108
|
|
|
$
|
248,630
|
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
117,153
|
|
|
100,000
|
|
|
116,384
|
|
||||
|
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
268,490
|
|
|
250,000
|
|
|
285,545
|
|
||||
|
6 ½% GO Zone Senior Notes Due 2035
|
|
89,000
|
|
|
106,491
|
|
|
89,000
|
|
|
106,504
|
|
||||
|
6 ½% IKE Zone Senior Notes Due 2035
|
|
65,000
|
|
|
76,741
|
|
|
65,000
|
|
|
77,784
|
|
||||
|
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
||||
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Domestic
|
|
$
|
880,044
|
|
|
$
|
1,102,101
|
|
|
$
|
944,378
|
|
|
Foreign
|
|
83,397
|
|
|
(18,183
|
)
|
|
(2,206
|
)
|
|||
|
|
|
$
|
963,441
|
|
|
$
|
1,083,918
|
|
|
$
|
942,172
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Current
|
|
|
|
|
|
|
||||||
|
Federal
|
|
$
|
225,617
|
|
|
$
|
300,610
|
|
|
$
|
215,903
|
|
|
State
|
|
23,966
|
|
|
37,351
|
|
|
22,249
|
|
|||
|
Foreign
|
|
9,029
|
|
|
1,974
|
|
|
(137
|
)
|
|||
|
|
|
258,612
|
|
|
339,935
|
|
|
238,015
|
|
|||
|
Deferred
|
|
|
|
|
|
|
||||||
|
Federal
|
|
29,820
|
|
|
40,950
|
|
|
94,471
|
|
|||
|
State
|
|
2,807
|
|
|
22,714
|
|
|
(556
|
)
|
|||
|
Foreign
|
|
7,157
|
|
|
(4,697
|
)
|
|
(183
|
)
|
|||
|
|
|
39,784
|
|
|
58,967
|
|
|
93,732
|
|
|||
|
Total provision
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
$
|
331,747
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Provision for federal income tax, at statutory rate
|
|
$
|
337,204
|
|
|
$
|
379,371
|
|
|
$
|
329,760
|
|
|
State income tax provision, net of federal income tax effect
|
|
17,403
|
|
|
40,012
|
|
|
14,364
|
|
|||
|
Foreign income tax rate differential
|
|
(13,002
|
)
|
|
3,640
|
|
|
519
|
|
|||
|
Manufacturing deduction
|
|
(24,185
|
)
|
|
(24,465
|
)
|
|
(16,275
|
)
|
|||
|
Contingent tax liability
|
|
—
|
|
|
(1,626
|
)
|
|
(404
|
)
|
|||
|
Noncontrolling interests
|
|
(6,662
|
)
|
|
(2,255
|
)
|
|
—
|
|
|||
|
Other, net
|
|
(12,362
|
)
|
|
4,225
|
|
|
3,783
|
|
|||
|
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
$
|
331,747
|
|
|
|
|
2015
|
|
2014
|
||||
|
Net operating loss carryforward
|
|
$
|
17,679
|
|
|
$
|
18,200
|
|
|
Credit carryforward
|
|
746
|
|
|
694
|
|
||
|
Accruals
|
|
62,204
|
|
|
62,845
|
|
||
|
Allowance for doubtful accounts
|
|
4,617
|
|
|
1,998
|
|
||
|
Inventories
|
|
8,663
|
|
|
11,437
|
|
||
|
Other
|
|
7,747
|
|
|
7,660
|
|
||
|
Deferred taxes assets—total
|
|
101,656
|
|
|
102,834
|
|
||
|
Property, plant and equipment
|
|
(423,381
|
)
|
|
(398,683
|
)
|
||
|
Turnaround costs
|
|
(1,467
|
)
|
|
(2,289
|
)
|
||
|
Basis difference—consolidated partnerships
|
|
(200,627
|
)
|
|
(194,480
|
)
|
||
|
Deferred tax liabilities—total
|
|
(625,475
|
)
|
|
(595,452
|
)
|
||
|
Valuation allowance
|
|
(16,345
|
)
|
|
(11,011
|
)
|
||
|
Total net deferred tax liabilities
|
|
$
|
(540,164
|
)
|
|
$
|
(503,629
|
)
|
|
|
|
|
|
|
||||
|
Balance sheet classifications
|
|
|
|
|
||||
|
Current deferred tax asset
|
|
$
|
35,439
|
|
|
$
|
32,437
|
|
|
Noncurrent deferred tax liability
|
|
(575,603
|
)
|
|
(536,066
|
)
|
||
|
Total net deferred tax liabilities
|
|
$
|
(540,164
|
)
|
|
$
|
(503,629
|
)
|
|
|
|
2015
|
|
2014
|
||||
|
Beginning balance
|
|
$
|
—
|
|
|
$
|
2,501
|
|
|
Reductions due to statutes of limitations expiring
|
|
—
|
|
|
(2,501
|
)
|
||
|
Ending balance
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
678,523
|
|
|
$
|
610,425
|
|
|
Less:
|
|
|
|
|
|
|
||||||
|
Net income attributable to participating securities
|
|
(2,825
|
)
|
|
(1,502
|
)
|
|
(2,562
|
)
|
|||
|
Net income attributable to common shareholders
|
|
$
|
643,185
|
|
|
$
|
677,021
|
|
|
$
|
607,863
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Weighted average common shares—basic
(1)
|
|
131,823,707
|
|
|
133,111,230
|
|
|
133,224,256
|
|
|||
|
Plus incremental shares from:
|
|
|
|
|
|
|
||||||
|
Assumed exercise of options
(1)
|
|
478,105
|
|
|
532,184
|
|
|
554,994
|
|
|||
|
Weighted average common shares—diluted
(1)
|
|
132,301,812
|
|
|
133,643,414
|
|
|
133,779,250
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Earnings per common share attributable to
Westlake Chemical Corporation:
(1)
|
|
|
|
|
|
|
||||||
|
Basic
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
|
$
|
4.57
|
|
|
Diluted
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
|
(1)
|
Share amounts and per share data for the year ended
December 31,
2013
have been restated to reflect the effect of a two-for-one stock split on March 18, 2014. See Note 9 for additional information.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Interest income
|
|
$
|
6,034
|
|
|
$
|
3,468
|
|
|
$
|
3,086
|
|
|
Dividend income
|
|
3,559
|
|
|
532
|
|
|
—
|
|
|||
|
Foreign exchange currency gains (losses), net
(1)
|
|
1,828
|
|
|
(7,382
|
)
|
|
(1,375
|
)
|
|||
|
Income from equity method investments
|
|
6,242
|
|
|
5,883
|
|
|
4,914
|
|
|||
|
Impairment of equity method investments
|
|
(4,925
|
)
|
|
(6,747
|
)
|
|
—
|
|
|||
|
Gain on acquisition and related expenses, net
|
|
20,430
|
|
|
—
|
|
|
—
|
|
|||
|
Gains (losses) from sales of securities, net
|
|
3,798
|
|
|
1,212
|
|
|
(19
|
)
|
|||
|
Other
|
|
1,304
|
|
|
313
|
|
|
184
|
|
|||
|
Other income (expense), net
|
|
$
|
38,270
|
|
|
$
|
(2,721
|
)
|
|
$
|
6,790
|
|
|
(1)
|
Aggregate foreign exchange currency gains and losses included in the consolidated statements of operations for the years ended
December 31, 2015
,
2014
and
2013
.
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Cash paid for:
|
|
|
|
|
|
|
||||||
|
Interest paid, net of interest capitalized
|
|
$
|
31,946
|
|
|
$
|
35,336
|
|
|
$
|
16,426
|
|
|
Income taxes paid
|
|
314,186
|
|
|
314,745
|
|
|
251,599
|
|
|||
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2015
|
|
2014
|
||||
|
Fair value of assets acquired
|
|
$
|
44,013
|
|
|
$
|
961,823
|
|
|
Fair value of investment before business combination, net of preexisting balances
|
|
(10,352
|
)
|
|
—
|
|
||
|
Noncontrolling interest acquired
|
|
(1,597
|
)
|
|
—
|
|
||
|
Cash paid
|
|
(5,518
|
)
|
|
(736,224
|
)
|
||
|
Liabilities assumed
|
|
$
|
26,546
|
|
|
$
|
225,599
|
|
|
Total proceeds from the initial public offering
|
|
$
|
310,500
|
|
|
Less: Offering Costs
|
|
(24,412
|
)
|
|
|
Net proceeds from the initial public offering
|
|
286,088
|
|
|
|
Less: Cash retained by OpCo
|
|
(55,419
|
)
|
|
|
Net proceeds distributed to the Company from the initial public offering
|
|
$
|
230,669
|
|
|
Fair value of consideration transferred—cash
|
|
$
|
5,518
|
|
|
Preexisting balances between the Company and Huasu, net
|
|
(8,538
|
)
|
|
|
Fair value of the Company's investment in Huasu before the business combination
(1)
|
|
18,890
|
|
|
|
Fair value of the noncontrolling interest in Huasu
(1)
|
|
1,597
|
|
|
|
|
|
$
|
17,467
|
|
|
|
|
|
||
|
Preliminary allocation of consideration transferred to net assets acquired:
|
|
|
||
|
Cash
|
|
$
|
21,300
|
|
|
Working capital, excluding inventory and cash
(2)
|
|
(5,461
|
)
|
|
|
Inventories
|
|
17,717
|
|
|
|
Property, plant and equipment
|
|
19,786
|
|
|
|
Other assets
|
|
7,760
|
|
|
|
Notes payable to banks
|
|
(21,085
|
)
|
|
|
Total identifiable net assets
|
|
40,017
|
|
|
|
Bargain purchase gain on acquisition
|
|
$
|
22,550
|
|
|
(1)
|
The fair values of the Company's
59.3%
equity interest and the noncontrolling interest were estimated using internally developed, unobservable inputs (Level 3 inputs in the fair value hierarchy of fair value accounting) based on a cost approach.
|
|
(2)
|
The fair value of accounts receivable acquired is
$2,515
, with the gross contractual amount being
$3,006
. The Company expects
$491
to be uncollectible.
|
|
|
|
Pro Forma
Year Ended December 31,
|
||||||
|
|
|
2014
|
|
2013
|
||||
|
Net sales
|
|
$
|
5,152,806
|
|
|
$
|
4,976,998
|
|
|
|
|
|
|
|
||||
|
Net income
|
|
$
|
737,913
|
|
|
$
|
666,202
|
|
|
Net income attributable to noncontrolling interests
|
|
6,493
|
|
|
—
|
|
||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
731,420
|
|
|
$
|
666,202
|
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
||||
|
Basic
|
|
$
|
5.48
|
|
|
$
|
4.98
|
|
|
Diluted
|
|
$
|
5.46
|
|
|
$
|
4.96
|
|
|
Fair value of consideration transferred:
|
|
|
||
|
Cash paid to Sellers
|
|
$
|
309,619
|
|
|
Cash deposited in escrow
(1)
|
|
13,390
|
|
|
|
Retirement of long-term debt as of July 31, 2014, on behalf of the Sellers
(2)
|
|
413,215
|
|
|
|
Total purchase consideration
|
|
$
|
736,224
|
|
|
|
|
|
||
|
Allocation of consideration transferred to net assets acquired:
|
|
|
||
|
Cash
|
|
$
|
125,137
|
|
|
Working capital, excluding inventory and cash
(3)
|
|
15,373
|
|
|
|
Inventories
(4)
|
|
114,961
|
|
|
|
Property, plant and equipment
|
|
469,484
|
|
|
|
Investments
|
|
51,552
|
|
|
|
Other assets
(5)
|
|
76,828
|
|
|
|
Intangible assets:
|
|
|
||
|
Trademarks and trade name (weighted average life of 20 years)
|
|
40,170
|
|
|
|
Developed technologies (weighted average life of 20 years)
|
|
31,600
|
|
|
|
Other intangibles (weighted average life of 9.4 years)
|
|
1,422
|
|
|
|
Deferred income tax asset—current
|
|
7,909
|
|
|
|
Deferred income tax asset—non-current
|
|
27,387
|
|
|
|
Pension obligation
|
|
(117,970
|
)
|
|
|
Other long-term liabilities
|
|
(10,723
|
)
|
|
|
Power purchase agreement liability
(6)
|
|
(10,826
|
)
|
|
|
Deferred income tax liability—current
|
|
(6,845
|
)
|
|
|
Deferred income tax liability—non-current
|
|
(79,235
|
)
|
|
|
Total identifiable net assets
|
|
736,224
|
|
|
|
Goodwill
(7)
|
|
—
|
|
|
|
Consideration transferred
|
|
$
|
736,224
|
|
|
(1)
|
None of the cash held in escrow is considered contingent consideration as it is expected to be released to the Sellers pending the Sellers' satisfaction of general representations and warranties made in connection with the execution of the purchase agreement.
|
|
(2)
|
Vinnolit's long-term debt paid on behalf of the Sellers was not legally assumed by Westlake in the acquisition and the retirement was a condition of the consummation of the purchase agreement. Therefore, the retirement has been included in the total purchase consideration.
|
|
(3)
|
The fair value of accounts receivable acquired is
$181,890
, with the gross contractual amount being
$183,833
. The Company expects
$1,943
to be uncollectable.
|
|
(4)
|
An adjustment of approximately
$16,900
was recorded to reflect Vinnolit's inventories at fair value and increased cost of sales by the same amount for the year ended December 31, 2014.
|
|
(5)
|
Included in other assets was a loan acquired that was repaid prior to December 31, 2014.
|
|
(6)
|
A liability arising from the unfavorable forward purchase contracts for the purchase of power was recognized at fair value. This liability will be amortized over a period of approximately
three
years, being the weighted-average life of the forward purchase contracts.
|
|
(7)
|
As the fair value of the net assets acquired equals consideration paid, no goodwill was recorded.
|
|
|
|
Operating
Leases
|
|
Capital
Leases
|
||||
|
2016
|
|
$
|
43,200
|
|
|
$
|
245
|
|
|
2017
|
|
42,293
|
|
|
245
|
|
||
|
2018
|
|
35,119
|
|
|
245
|
|
||
|
2019
|
|
29,164
|
|
|
245
|
|
||
|
2020
|
|
24,124
|
|
|
245
|
|
||
|
Thereafter
|
|
582,327
|
|
|
779
|
|
||
|
Total minimum lease payments
|
|
$
|
756,227
|
|
|
$
|
2,004
|
|
|
Less: Imputed interest costs
|
|
|
|
(519
|
)
|
|||
|
Present value of net minimum lease payments
|
|
|
|
$
|
1,485
|
|
||
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Net external sales
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
|
|
|
|
|
||||||
|
Polyethylene
|
|
$
|
1,650,964
|
|
|
$
|
1,922,535
|
|
|
$
|
1,750,292
|
|
|
Styrene, feedstock and other
|
|
609,149
|
|
|
801,155
|
|
|
803,377
|
|
|||
|
Total olefins
|
|
2,260,113
|
|
|
2,723,690
|
|
|
2,553,669
|
|
|||
|
Vinyls
|
|
|
|
|
|
|
||||||
|
PVC, caustic soda and other
|
|
1,718,359
|
|
|
1,203,332
|
|
|
800,658
|
|
|||
|
Building products
|
|
484,864
|
|
|
488,328
|
|
|
405,157
|
|
|||
|
Total vinyls
|
|
2,203,223
|
|
|
1,691,660
|
|
|
1,205,815
|
|
|||
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
|
|
|
|
|
|
|
||||||
|
Intersegment sales
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
106,861
|
|
|
$
|
146,539
|
|
|
$
|
320,909
|
|
|
Vinyls
|
|
1,493
|
|
|
1,385
|
|
|
1,502
|
|
|||
|
|
|
$
|
108,354
|
|
|
$
|
147,924
|
|
|
$
|
322,411
|
|
|
|
|
|
|
|
|
|
||||||
|
Income (loss) from operations
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
747,436
|
|
|
$
|
1,013,825
|
|
|
$
|
833,249
|
|
|
Vinyls
|
|
254,452
|
|
|
142,740
|
|
|
154,684
|
|
|||
|
Corporate and other
|
|
(42,061
|
)
|
|
(32,574
|
)
|
|
(34,469
|
)
|
|||
|
|
|
$
|
959,827
|
|
|
$
|
1,123,991
|
|
|
$
|
953,464
|
|
|
|
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
110,684
|
|
|
$
|
106,244
|
|
|
$
|
102,938
|
|
|
Vinyls
|
|
134,546
|
|
|
101,666
|
|
|
54,371
|
|
|||
|
Corporate and other
|
|
527
|
|
|
576
|
|
|
499
|
|
|||
|
|
|
$
|
245,757
|
|
|
$
|
208,486
|
|
|
$
|
157,808
|
|
|
|
|
|
|
|
|
|
||||||
|
Other income (expense), net
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
4,656
|
|
|
$
|
6,102
|
|
|
$
|
7,410
|
|
|
Vinyls
|
|
8,540
|
|
|
2,680
|
|
|
(1,858
|
)
|
|||
|
Corporate and other
|
|
25,074
|
|
|
(11,503
|
)
|
|
1,238
|
|
|||
|
|
|
$
|
38,270
|
|
|
$
|
(2,721
|
)
|
|
$
|
6,790
|
|
|
|
|
|
|
|
|
|
||||||
|
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
242,516
|
|
|
$
|
354,159
|
|
|
$
|
288,214
|
|
|
Vinyls
|
|
64,456
|
|
|
52,249
|
|
|
48,296
|
|
|||
|
Corporate and other
|
|
(8,576
|
)
|
|
(7,506
|
)
|
|
(4,763
|
)
|
|||
|
|
|
$
|
298,396
|
|
|
$
|
398,902
|
|
|
$
|
331,747
|
|
|
|
|
|
|
|
|
|
||||||
|
Capital expenditures
|
|
|
|
|
|
|
||||||
|
Olefins
|
|
$
|
304,873
|
|
|
$
|
188,729
|
|
|
$
|
145,542
|
|
|
Vinyls
|
|
176,582
|
|
|
237,992
|
|
|
531,939
|
|
|||
|
Corporate and other
|
|
9,971
|
|
|
4,383
|
|
|
1,741
|
|
|||
|
|
|
$
|
491,426
|
|
|
$
|
431,104
|
|
|
$
|
679,222
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||
|
Total assets
|
|
|
|
|
||||
|
Olefins
|
|
$
|
1,869,888
|
|
|
$
|
1,785,895
|
|
|
Vinyls
|
|
2,638,833
|
|
|
2,618,646
|
|
||
|
Corporate and other
|
|
1,066,531
|
|
|
809,449
|
|
||
|
|
|
$
|
5,575,252
|
|
|
$
|
5,213,990
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Income from operations for reportable segments
|
|
$
|
959,827
|
|
|
$
|
1,123,991
|
|
|
$
|
953,464
|
|
|
Interest expense
|
|
(34,656
|
)
|
|
(37,352
|
)
|
|
(18,082
|
)
|
|||
|
Other income (expense), net
|
|
38,270
|
|
|
(2,721
|
)
|
|
6,790
|
|
|||
|
Income before income taxes
|
|
$
|
963,441
|
|
|
$
|
1,083,918
|
|
|
$
|
942,172
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Sales to external customers
(1)
|
|
|
|
|
|
|
||||||
|
United States
|
|
$
|
3,133,395
|
|
|
$
|
3,596,091
|
|
|
$
|
3,404,378
|
|
|
Foreign
|
|
|
|
|
|
|
||||||
|
Germany
|
|
394,459
|
|
|
198,921
|
|
|
3,942
|
|
|||
|
Canada
|
|
195,790
|
|
|
217,567
|
|
|
214,162
|
|
|||
|
Switzerland
|
|
106,750
|
|
|
89,214
|
|
|
54,637
|
|
|||
|
Italy
|
|
90,237
|
|
|
36,823
|
|
|
55
|
|
|||
|
France
|
|
58,727
|
|
|
27,521
|
|
|
8,207
|
|
|||
|
Other
|
|
483,978
|
|
|
249,213
|
|
|
74,103
|
|
|||
|
|
|
$
|
4,463,336
|
|
|
$
|
4,415,350
|
|
|
$
|
3,759,484
|
|
|
|
|
December 31, 2015
|
|
December 31, 2014
|
||||
|
Long-lived assets
|
|
|
|
|
||||
|
United States
|
|
$
|
2,588,366
|
|
|
$
|
2,319,572
|
|
|
Foreign
|
|
|
|
|
||||
|
Germany
|
|
379,262
|
|
|
417,702
|
|
||
|
Other
|
|
36,439
|
|
|
20,283
|
|
||
|
|
|
$
|
3,004,067
|
|
|
$
|
2,757,557
|
|
|
(1)
|
Revenues are attributed to countries based on location of customer.
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash and cash equivalents
|
|
$
|
303,131
|
|
|
$
|
6,828
|
|
|
$
|
163,430
|
|
|
$
|
189,136
|
|
|
$
|
—
|
|
|
$
|
662,525
|
|
|
Marketable securities
|
|
520,144
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
520,144
|
|
||||||
|
Accounts receivable, net
|
|
10,943
|
|
|
2,183,276
|
|
|
51,582
|
|
|
113,321
|
|
|
(1,850,590
|
)
|
|
508,532
|
|
||||||
|
Inventories
|
|
—
|
|
|
326,588
|
|
|
3,879
|
|
|
103,593
|
|
|
—
|
|
|
434,060
|
|
||||||
|
Prepaid expenses and other current assets
|
|
2,201
|
|
|
12,166
|
|
|
267
|
|
|
2,734
|
|
|
(2,879
|
)
|
|
14,489
|
|
||||||
|
Deferred income taxes
|
|
702
|
|
|
32,787
|
|
|
—
|
|
|
1,950
|
|
|
—
|
|
|
35,439
|
|
||||||
|
Total current assets
|
|
837,121
|
|
|
2,561,645
|
|
|
219,158
|
|
|
410,734
|
|
|
(1,853,469
|
)
|
|
2,175,189
|
|
||||||
|
Property, plant and equipment, net
|
|
—
|
|
|
1,567,897
|
|
|
1,020,469
|
|
|
415,701
|
|
|
—
|
|
|
3,004,067
|
|
||||||
|
Equity investments
|
|
4,991,167
|
|
|
1,207,679
|
|
|
—
|
|
|
469,915
|
|
|
(6,659,553
|
)
|
|
9,208
|
|
||||||
|
Other assets, net
|
|
17,896
|
|
|
450,428
|
|
|
44,157
|
|
|
129,539
|
|
|
(255,232
|
)
|
|
386,788
|
|
||||||
|
Total assets
|
|
$
|
5,846,184
|
|
|
$
|
5,787,649
|
|
|
$
|
1,283,784
|
|
|
$
|
1,425,889
|
|
|
$
|
(8,768,254
|
)
|
|
$
|
5,575,252
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Accounts and notes payable
|
|
$
|
1,817,963
|
|
|
$
|
121,820
|
|
|
$
|
33,901
|
|
|
$
|
87,510
|
|
|
$
|
(1,825,865
|
)
|
|
$
|
235,329
|
|
|
Accrued liabilities
|
|
9,117
|
|
|
195,785
|
|
|
21,873
|
|
|
88,142
|
|
|
(27,604
|
)
|
|
287,313
|
|
||||||
|
Total current liabilities
|
|
1,827,080
|
|
|
317,605
|
|
|
55,774
|
|
|
175,652
|
|
|
(1,853,469
|
)
|
|
522,642
|
|
||||||
|
Long-term debt
|
|
753,226
|
|
|
10,889
|
|
|
248,665
|
|
|
—
|
|
|
(248,665
|
)
|
|
764,115
|
|
||||||
|
Deferred income taxes
|
|
—
|
|
|
532,837
|
|
|
1,392
|
|
|
47,941
|
|
|
(6,567
|
)
|
|
575,603
|
|
||||||
|
Other liabilities
|
|
—
|
|
|
49,334
|
|
|
—
|
|
|
101,627
|
|
|
—
|
|
|
150,961
|
|
||||||
|
Total liabilities
|
|
2,580,306
|
|
|
910,665
|
|
|
305,831
|
|
|
325,220
|
|
|
(2,108,701
|
)
|
|
2,013,321
|
|
||||||
|
Total Westlake Chemical Corporation stockholders' equity
|
|
3,265,878
|
|
|
4,876,984
|
|
|
977,953
|
|
|
804,616
|
|
|
(6,659,553
|
)
|
|
3,265,878
|
|
||||||
|
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
296,053
|
|
|
—
|
|
|
296,053
|
|
||||||
|
Total equity
|
|
3,265,878
|
|
|
4,876,984
|
|
|
977,953
|
|
|
1,100,669
|
|
|
(6,659,553
|
)
|
|
3,561,931
|
|
||||||
|
Total liabilities and equity
|
|
$
|
5,846,184
|
|
|
$
|
5,787,649
|
|
|
$
|
1,283,784
|
|
|
$
|
1,425,889
|
|
|
$
|
(8,768,254
|
)
|
|
$
|
5,575,252
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash and cash equivalents
|
|
$
|
655,947
|
|
|
$
|
3,057
|
|
|
$
|
131,545
|
|
|
$
|
90,052
|
|
|
$
|
—
|
|
|
$
|
880,601
|
|
|
Accounts receivable, net
|
|
8,451
|
|
|
1,454,709
|
|
|
56,049
|
|
|
135,133
|
|
|
(1,093,676
|
)
|
|
560,666
|
|
||||||
|
Inventories
|
|
—
|
|
|
414,975
|
|
|
6,634
|
|
|
104,167
|
|
|
—
|
|
|
525,776
|
|
||||||
|
Prepaid expenses and other current assets
|
|
172
|
|
|
9,485
|
|
|
212
|
|
|
1,938
|
|
|
—
|
|
|
11,807
|
|
||||||
|
Deferred income taxes
|
|
409
|
|
|
29,832
|
|
|
—
|
|
|
2,196
|
|
|
—
|
|
|
32,437
|
|
||||||
|
Total current assets
|
|
664,979
|
|
|
1,912,058
|
|
|
194,440
|
|
|
333,486
|
|
|
(1,093,676
|
)
|
|
2,011,287
|
|
||||||
|
Property, plant and equipment, net
|
|
—
|
|
|
1,477,515
|
|
|
842,057
|
|
|
437,985
|
|
|
—
|
|
|
2,757,557
|
|
||||||
|
Equity investments
|
|
4,033,378
|
|
|
1,237,080
|
|
|
—
|
|
|
352,550
|
|
|
(5,561,703
|
)
|
|
61,305
|
|
||||||
|
Other assets, net
|
|
30,543
|
|
|
387,325
|
|
|
57,733
|
|
|
141,948
|
|
|
(233,708
|
)
|
|
383,841
|
|
||||||
|
Total assets
|
|
$
|
4,728,900
|
|
|
$
|
5,013,978
|
|
|
$
|
1,094,230
|
|
|
$
|
1,265,969
|
|
|
$
|
(6,889,087
|
)
|
|
$
|
5,213,990
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Accounts payable
|
|
$
|
1,055,527
|
|
|
$
|
160,834
|
|
|
$
|
17,680
|
|
|
$
|
95,856
|
|
|
$
|
(1,068,835
|
)
|
|
$
|
261,062
|
|
|
Accrued liabilities
|
|
8,754
|
|
|
203,608
|
|
|
11,225
|
|
|
77,372
|
|
|
(24,841
|
)
|
|
276,118
|
|
||||||
|
Total current liabilities
|
|
1,064,281
|
|
|
364,442
|
|
|
28,905
|
|
|
173,228
|
|
|
(1,093,676
|
)
|
|
537,180
|
|
||||||
|
Long-term debt
|
|
753,108
|
|
|
10,889
|
|
|
227,638
|
|
|
—
|
|
|
(227,638
|
)
|
|
763,997
|
|
||||||
|
Deferred income taxes
|
|
—
|
|
|
497,919
|
|
|
1,848
|
|
|
42,369
|
|
|
(6,070
|
)
|
|
536,066
|
|
||||||
|
Other liabilities
|
|
—
|
|
|
43,452
|
|
|
—
|
|
|
131,407
|
|
|
—
|
|
|
174,859
|
|
||||||
|
Total liabilities
|
|
1,817,389
|
|
|
916,702
|
|
|
258,391
|
|
|
347,004
|
|
|
(1,327,384
|
)
|
|
2,012,102
|
|
||||||
|
Total Westlake Chemical Corporation stockholders' equity
|
|
2,911,511
|
|
|
4,097,276
|
|
|
835,839
|
|
|
628,588
|
|
|
(5,561,703
|
)
|
|
2,911,511
|
|
||||||
|
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
290,377
|
|
|
—
|
|
|
290,377
|
|
||||||
|
Total equity
|
|
2,911,511
|
|
|
4,097,276
|
|
|
835,839
|
|
|
918,965
|
|
|
(5,561,703
|
)
|
|
3,201,888
|
|
||||||
|
Total liabilities and equity
|
|
$
|
4,728,900
|
|
|
$
|
5,013,978
|
|
|
$
|
1,094,230
|
|
|
$
|
1,265,969
|
|
|
$
|
(6,889,087
|
)
|
|
$
|
5,213,990
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
3,660,393
|
|
|
$
|
1,007,221
|
|
|
$
|
1,039,165
|
|
|
$
|
(1,243,443
|
)
|
|
$
|
4,463,336
|
|
|
Cost of sales
|
|
—
|
|
|
2,944,420
|
|
|
624,339
|
|
|
933,007
|
|
|
(1,223,621
|
)
|
|
3,278,145
|
|
||||||
|
Gross profit
|
|
—
|
|
|
715,973
|
|
|
382,882
|
|
|
106,158
|
|
|
(19,822
|
)
|
|
1,185,191
|
|
||||||
|
Selling, general and administrative expenses
|
|
2,478
|
|
|
167,431
|
|
|
20,138
|
|
|
55,139
|
|
|
(19,822
|
)
|
|
225,364
|
|
||||||
|
(Loss) income from operations
|
|
(2,478
|
)
|
|
548,542
|
|
|
362,744
|
|
|
51,019
|
|
|
—
|
|
|
959,827
|
|
||||||
|
Interest expense
|
|
(42,197
|
)
|
|
(10
|
)
|
|
(2,691
|
)
|
|
(521
|
)
|
|
10,763
|
|
|
(34,656
|
)
|
||||||
|
Other income (expense), net
|
|
19,614
|
|
|
1,033
|
|
|
(63
|
)
|
|
28,449
|
|
|
(10,763
|
)
|
|
38,270
|
|
||||||
|
(Loss) income before income taxes
|
|
(25,061
|
)
|
|
549,565
|
|
|
359,990
|
|
|
78,947
|
|
|
—
|
|
|
963,441
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(7,237
|
)
|
|
288,329
|
|
|
672
|
|
|
16,632
|
|
|
—
|
|
|
298,396
|
|
||||||
|
Equity in net income of subsidiaries
|
|
663,834
|
|
|
314,026
|
|
|
—
|
|
|
45,292
|
|
|
(1,023,152
|
)
|
|
—
|
|
||||||
|
Net income
|
|
646,010
|
|
|
575,262
|
|
|
359,318
|
|
|
107,607
|
|
|
(1,023,152
|
)
|
|
665,045
|
|
||||||
|
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,035
|
|
|
—
|
|
|
19,035
|
|
||||||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
646,010
|
|
|
$
|
575,262
|
|
|
$
|
359,318
|
|
|
$
|
88,572
|
|
|
$
|
(1,023,152
|
)
|
|
$
|
646,010
|
|
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
596,151
|
|
|
$
|
572,731
|
|
|
$
|
359,318
|
|
|
$
|
42,143
|
|
|
$
|
(974,192
|
)
|
|
$
|
596,151
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
3,727,361
|
|
|
$
|
1,749,700
|
|
|
$
|
475,401
|
|
|
$
|
(1,537,112
|
)
|
|
$
|
4,415,350
|
|
|
Cost of sales
|
|
—
|
|
|
3,162,246
|
|
|
1,003,888
|
|
|
447,676
|
|
|
(1,515,810
|
)
|
|
3,098,000
|
|
||||||
|
Gross profit
|
|
—
|
|
|
565,115
|
|
|
745,812
|
|
|
27,725
|
|
|
(21,302
|
)
|
|
1,317,350
|
|
||||||
|
Selling, general and administrative expenses
|
|
2,082
|
|
|
144,987
|
|
|
26,870
|
|
|
40,722
|
|
|
(21,302
|
)
|
|
193,359
|
|
||||||
|
(Loss) income from operations
|
|
(2,082
|
)
|
|
420,128
|
|
|
718,942
|
|
|
(12,997
|
)
|
|
—
|
|
|
1,123,991
|
|
||||||
|
Interest expense
|
|
(39,763
|
)
|
|
(10
|
)
|
|
(10,499
|
)
|
|
(492
|
)
|
|
13,412
|
|
|
(37,352
|
)
|
||||||
|
Other income (expense), net
|
|
21,001
|
|
|
(4,921
|
)
|
|
3,151
|
|
|
(8,540
|
)
|
|
(13,412
|
)
|
|
(2,721
|
)
|
||||||
|
(Loss) income before income taxes
|
|
(20,844
|
)
|
|
415,197
|
|
|
711,594
|
|
|
(22,029
|
)
|
|
—
|
|
|
1,083,918
|
|
||||||
|
Provision for (benefit from) income taxes
|
|
248
|
|
|
202,501
|
|
|
199,388
|
|
|
(3,235
|
)
|
|
—
|
|
|
398,902
|
|
||||||
|
Equity in net income of subsidiaries
|
|
699,615
|
|
|
496,244
|
|
|
—
|
|
|
15,962
|
|
|
(1,211,821
|
)
|
|
—
|
|
||||||
|
Net income (loss)
|
|
678,523
|
|
|
708,940
|
|
|
512,206
|
|
|
(2,832
|
)
|
|
(1,211,821
|
)
|
|
685,016
|
|
||||||
|
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,493
|
|
|
—
|
|
|
6,493
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
678,523
|
|
|
$
|
708,940
|
|
|
$
|
512,206
|
|
|
$
|
(9,325
|
)
|
|
$
|
(1,211,821
|
)
|
|
$
|
678,523
|
|
|
Comprehensive income (loss) attributable to
Westlake Chemical Corporation
|
|
$
|
601,706
|
|
|
$
|
703,148
|
|
|
$
|
512,206
|
|
|
$
|
(80,407
|
)
|
|
$
|
(1,134,947
|
)
|
|
$
|
601,706
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
3,195,406
|
|
|
$
|
2,127,747
|
|
|
$
|
48,016
|
|
|
$
|
(1,611,685
|
)
|
|
$
|
3,759,484
|
|
|
Cost of sales
|
|
—
|
|
|
2,971,258
|
|
|
1,255,140
|
|
|
43,333
|
|
|
(1,611,685
|
)
|
|
2,658,046
|
|
||||||
|
Gross profit
|
|
—
|
|
|
224,148
|
|
|
872,607
|
|
|
4,683
|
|
|
—
|
|
|
1,101,438
|
|
||||||
|
Selling, general and administrative expenses
|
|
2,128
|
|
|
114,211
|
|
|
25,451
|
|
|
6,184
|
|
|
—
|
|
|
147,974
|
|
||||||
|
(Loss) income from operations
|
|
(2,128
|
)
|
|
109,937
|
|
|
847,156
|
|
|
(1,501
|
)
|
|
—
|
|
|
953,464
|
|
||||||
|
Interest expense
|
|
(18,030
|
)
|
|
(52
|
)
|
|
(8,032
|
)
|
|
—
|
|
|
8,032
|
|
|
(18,082
|
)
|
||||||
|
Other income (expense), net
|
|
11,798
|
|
|
(2,438
|
)
|
|
7,701
|
|
|
(2,239
|
)
|
|
(8,032
|
)
|
|
6,790
|
|
||||||
|
(Loss) income before income taxes
|
|
(8,360
|
)
|
|
107,447
|
|
|
846,825
|
|
|
(3,740
|
)
|
|
—
|
|
|
942,172
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(2,031
|
)
|
|
34,340
|
|
|
300,279
|
|
|
(841
|
)
|
|
—
|
|
|
331,747
|
|
||||||
|
Equity in net income of subsidiaries
|
|
616,754
|
|
|
546,546
|
|
|
—
|
|
|
—
|
|
|
(1,163,300
|
)
|
|
—
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
610,425
|
|
|
$
|
619,653
|
|
|
$
|
546,546
|
|
|
$
|
(2,899
|
)
|
|
$
|
(1,163,300
|
)
|
|
$
|
610,425
|
|
|
Comprehensive income (loss) attributable to
Westlake Chemical Corporation
|
|
$
|
618,649
|
|
|
$
|
629,308
|
|
|
$
|
546,546
|
|
|
$
|
(4,506
|
)
|
|
$
|
(1,171,348
|
)
|
|
$
|
618,649
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income
|
|
$
|
646,010
|
|
|
$
|
575,262
|
|
|
$
|
359,318
|
|
|
$
|
107,607
|
|
|
$
|
(1,023,152
|
)
|
|
$
|
665,045
|
|
|
Adjustments to reconcile net income to net cash
(used for) provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
2,004
|
|
|
124,897
|
|
|
81,210
|
|
|
39,650
|
|
|
—
|
|
|
247,761
|
|
||||||
|
Deferred income taxes
|
|
(285
|
)
|
|
33,369
|
|
|
(456
|
)
|
|
7,156
|
|
|
—
|
|
|
39,784
|
|
||||||
|
Net changes in working capital and other
|
|
(660,777
|
)
|
|
(368,494
|
)
|
|
19,175
|
|
|
113,190
|
|
|
1,023,152
|
|
|
126,246
|
|
||||||
|
Net cash (used for) provided by operating activities
|
|
(13,048
|
)
|
|
365,034
|
|
|
459,247
|
|
|
267,603
|
|
|
—
|
|
|
1,078,836
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,782
|
|
|
—
|
|
|
15,782
|
|
||||||
|
Additions to property, plant and equipment
|
|
—
|
|
|
(215,405
|
)
|
|
(231,185
|
)
|
|
(44,836
|
)
|
|
—
|
|
|
(491,426
|
)
|
||||||
|
Proceeds from disposition of assets
|
|
—
|
|
|
18
|
|
|
—
|
|
|
31
|
|
|
—
|
|
|
49
|
|
||||||
|
Proceeds from disposition of equity method investment
|
|
—
|
|
|
27,865
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
27,865
|
|
||||||
|
Proceeds from sales and maturities of securities
|
|
48,900
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
48,900
|
|
||||||
|
Purchase of securities
|
|
(556,211
|
)
|
|
(48,887
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(605,098
|
)
|
||||||
|
Settlements of derivative instruments
|
|
—
|
|
|
(2,248
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,248
|
)
|
||||||
|
Net cash used for investing activities
|
|
(507,311
|
)
|
|
(238,657
|
)
|
|
(231,185
|
)
|
|
(29,023
|
)
|
|
—
|
|
|
(1,006,176
|
)
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Intercompany financing
|
|
418,844
|
|
|
(585,007
|
)
|
|
156,368
|
|
|
9,795
|
|
|
—
|
|
|
—
|
|
||||||
|
Intercompany financing—OpCo
|
|
—
|
|
|
135,341
|
|
|
(135,341
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Dividends paid
|
|
(91,551
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(91,551
|
)
|
||||||
|
Distributions paid
|
|
—
|
|
|
327,060
|
|
|
(352,545
|
)
|
|
10,629
|
|
|
—
|
|
|
(14,856
|
)
|
||||||
|
Purchase of limited partner interests
|
|
—
|
|
|
—
|
|
|
135,341
|
|
|
(135,341
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Proceeds from exercise of stock options
|
|
1,063
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,063
|
|
||||||
|
Proceeds from issuance of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52,960
|
|
|
—
|
|
|
52,960
|
|
||||||
|
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(73,615
|
)
|
|
—
|
|
|
(73,615
|
)
|
||||||
|
Repurchase of common stock for treasury
|
|
(162,459
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(162,459
|
)
|
||||||
|
Windfall tax benefits from share-based payment arrangements
|
|
1,646
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,646
|
|
||||||
|
Net cash provided by (used for) financing activities
|
|
$
|
167,543
|
|
|
$
|
(122,606
|
)
|
|
$
|
(196,177
|
)
|
|
$
|
(135,572
|
)
|
|
$
|
—
|
|
|
$
|
(286,812
|
)
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(3,924
|
)
|
|
$
|
—
|
|
|
$
|
(3,924
|
)
|
|
Net (decrease) increase in cash and cash equivalents
|
|
(352,816
|
)
|
|
3,771
|
|
|
31,885
|
|
|
99,084
|
|
|
—
|
|
|
(218,076
|
)
|
||||||
|
Cash and cash equivalents at beginning of the year
|
|
655,947
|
|
|
3,057
|
|
|
131,545
|
|
|
90,052
|
|
|
—
|
|
|
880,601
|
|
||||||
|
Cash and cash equivalents at end of the year
|
|
$
|
303,131
|
|
|
$
|
6,828
|
|
|
$
|
163,430
|
|
|
$
|
189,136
|
|
|
$
|
—
|
|
|
$
|
662,525
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
|
$
|
678,523
|
|
|
$
|
708,940
|
|
|
$
|
512,206
|
|
|
$
|
(2,832
|
)
|
|
$
|
(1,211,821
|
)
|
|
$
|
685,016
|
|
|
Adjustments to reconcile net income (loss) to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
1,673
|
|
|
111,389
|
|
|
77,611
|
|
|
19,486
|
|
|
—
|
|
|
210,159
|
|
||||||
|
Deferred income taxes
|
|
(288
|
)
|
|
55,344
|
|
|
8,608
|
|
|
(4,697
|
)
|
|
—
|
|
|
58,967
|
|
||||||
|
Net changes in working capital and other
|
|
(706,043
|
)
|
|
(1,077,982
|
)
|
|
4,879
|
|
|
645,559
|
|
|
1,211,821
|
|
|
78,234
|
|
||||||
|
Net cash (used for) provided by operating activities
|
|
(26,135
|
)
|
|
(202,309
|
)
|
|
603,304
|
|
|
657,516
|
|
|
—
|
|
|
1,032,376
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(611,087
|
)
|
|
—
|
|
|
(611,087
|
)
|
||||||
|
Additions to property, plant and equipment
|
|
—
|
|
|
(209,111
|
)
|
|
(202,823
|
)
|
|
(19,170
|
)
|
|
—
|
|
|
(431,104
|
)
|
||||||
|
Proceeds from disposition of assets
|
|
—
|
|
|
180
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
181
|
|
||||||
|
Proceeds from repayment of loan acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
45,923
|
|
|
—
|
|
|
45,923
|
|
||||||
|
Proceeds from sales and maturities of securities
|
|
342,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
342,045
|
|
||||||
|
Purchase of securities
|
|
(117,332
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(117,332
|
)
|
||||||
|
Settlements of derivative instruments
|
|
—
|
|
|
(1,698
|
)
|
|
(133
|
)
|
|
—
|
|
|
—
|
|
|
(1,831
|
)
|
||||||
|
Net cash provided by (used for) investing activities
|
|
224,713
|
|
|
(210,629
|
)
|
|
(202,956
|
)
|
|
(584,333
|
)
|
|
—
|
|
|
(773,205
|
)
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Intercompany financing
|
|
155,665
|
|
|
(244,122
|
)
|
|
102,702
|
|
|
(14,245
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Net distributions prior to Westlake Partners initial public offering
|
|
—
|
|
|
448,101
|
|
|
(448,101
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Capitalized debt issuance costs
|
|
(1,186
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,186
|
)
|
||||||
|
Dividends paid
|
|
(77,656
|
)
|
|
151,729
|
|
|
(151,729
|
)
|
|
—
|
|
|
—
|
|
|
(77,656
|
)
|
||||||
|
Distributions paid
|
|
—
|
|
|
54,060
|
|
|
(57,763
|
)
|
|
1,499
|
|
|
—
|
|
|
(2,204
|
)
|
||||||
|
Net proceeds from issuance of Westlake Partners common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
—
|
|
|
286,088
|
|
||||||
|
Purchase of limited partner interests
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
(286,088
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Proceeds from exercise of stock options
|
|
5,524
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,524
|
|
||||||
|
Repurchase of common stock for treasury
|
|
(52,630
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,630
|
)
|
||||||
|
Windfall tax benefits from share-based payment arrangements
|
|
6,704
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,704
|
|
||||||
|
Net cash provided by (used for) financing activities
|
|
$
|
36,421
|
|
|
$
|
409,768
|
|
|
$
|
(268,803
|
)
|
|
$
|
(12,746
|
)
|
|
$
|
—
|
|
|
$
|
164,640
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(4,511
|
)
|
|
$
|
—
|
|
|
$
|
(4,511
|
)
|
|
Net increase (decrease) in cash and cash equivalents
|
|
234,999
|
|
|
(3,170
|
)
|
|
131,545
|
|
|
55,926
|
|
|
—
|
|
|
419,300
|
|
||||||
|
Cash and cash equivalents at beginning of the year
|
|
420,948
|
|
|
6,227
|
|
|
—
|
|
|
34,126
|
|
|
—
|
|
|
461,301
|
|
||||||
|
Cash and cash equivalents at end of the year
|
|
$
|
655,947
|
|
|
$
|
3,057
|
|
|
$
|
131,545
|
|
|
$
|
90,052
|
|
|
$
|
—
|
|
|
$
|
880,601
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
|
$
|
610,425
|
|
|
$
|
619,653
|
|
|
$
|
546,546
|
|
|
$
|
(2,899
|
)
|
|
$
|
(1,163,300
|
)
|
|
$
|
610,425
|
|
|
Adjustments to reconcile net income (loss) to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
1,459
|
|
|
81,897
|
|
|
73,463
|
|
|
2,448
|
|
|
—
|
|
|
159,267
|
|
||||||
|
Deferred income taxes
|
|
74
|
|
|
56,787
|
|
|
37,054
|
|
|
(183
|
)
|
|
—
|
|
|
93,732
|
|
||||||
|
Net changes in working capital and other
|
|
(622,194
|
)
|
|
(607,033
|
)
|
|
(54,554
|
)
|
|
9,786
|
|
|
1,163,300
|
|
|
(110,695
|
)
|
||||||
|
Net cash (used for) provided by operating activities
|
|
(10,236
|
)
|
|
151,304
|
|
|
602,509
|
|
|
9,152
|
|
|
—
|
|
|
752,729
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Acquisition of business
|
|
—
|
|
|
(178,309
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(178,309
|
)
|
||||||
|
Additions to equity investments
|
|
—
|
|
|
(23,338
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(23,338
|
)
|
||||||
|
Additions to property, plant and equipment
|
|
—
|
|
|
(453,538
|
)
|
|
(223,130
|
)
|
|
(2,554
|
)
|
|
—
|
|
|
(679,222
|
)
|
||||||
|
Construction of assets pending sale-leaseback
|
|
—
|
|
|
(136
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(136
|
)
|
||||||
|
Proceeds from disposition of assets
|
|
—
|
|
|
75
|
|
|
—
|
|
|
76
|
|
|
—
|
|
|
151
|
|
||||||
|
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
—
|
|
|
—
|
|
|
167
|
|
|
—
|
|
|
167
|
|
||||||
|
Proceeds from sales and maturities of securities
|
|
252,519
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
252,519
|
|
||||||
|
Purchase of securities
|
|
(367,150
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(367,150
|
)
|
||||||
|
Settlements of derivative instruments
|
|
—
|
|
|
—
|
|
|
(6,920
|
)
|
|
—
|
|
|
—
|
|
|
(6,920
|
)
|
||||||
|
Net cash used for investing activities
|
|
(114,631
|
)
|
|
(655,246
|
)
|
|
(230,050
|
)
|
|
(2,311
|
)
|
|
—
|
|
|
(1,002,238
|
)
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Intercompany financing
|
|
(128,798
|
)
|
|
(100,330
|
)
|
|
231,067
|
|
|
(1,939
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Net distributions prior to Westlake Partners initial public offering
|
|
—
|
|
|
603,526
|
|
|
(603,526
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Dividends paid
|
|
(55,236
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,236
|
)
|
||||||
|
Proceeds from exercise of stock options
|
|
3,437
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,437
|
|
||||||
|
Repurchase of common stock for treasury
|
|
(32,918
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32,918
|
)
|
||||||
|
Windfall tax benefits from share-based payment arrangements
|
|
5,449
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,449
|
|
||||||
|
Net cash (used for) provided by financing activities
|
|
$
|
(208,066
|
)
|
|
$
|
503,196
|
|
|
$
|
(372,459
|
)
|
|
$
|
(1,939
|
)
|
|
$
|
—
|
|
|
$
|
(79,268
|
)
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Net (decrease) increase in cash and cash equivalents
|
|
$
|
(332,933
|
)
|
|
$
|
(746
|
)
|
|
$
|
—
|
|
|
$
|
4,902
|
|
|
$
|
—
|
|
|
$
|
(328,777
|
)
|
|
Cash and cash equivalents at beginning of the year
|
|
753,881
|
|
|
6,973
|
|
|
—
|
|
|
29,224
|
|
|
—
|
|
|
790,078
|
|
||||||
|
Cash and cash equivalents at end of the year
|
|
$
|
420,948
|
|
|
$
|
6,227
|
|
|
$
|
—
|
|
|
$
|
34,126
|
|
|
$
|
—
|
|
|
$
|
461,301
|
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
|
March 31,
2015 |
|
June 30,
2015 |
|
September 30,
2015 |
|
December 31,
2015 |
||||||||
|
Net sales
|
|
$
|
1,103,531
|
|
|
$
|
1,185,002
|
|
|
$
|
1,188,037
|
|
|
$
|
986,766
|
|
|
Gross profit
|
|
284,546
|
|
|
353,181
|
|
|
311,276
|
|
|
236,188
|
|
||||
|
Income from operations
|
|
229,280
|
|
|
295,374
|
|
|
254,028
|
|
|
181,145
|
|
||||
|
Net income attributable to
Westlake Chemical Corporation
|
|
146,342
|
|
|
205,095
|
|
|
183,604
|
|
|
110,969
|
|
||||
|
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
1.10
|
|
|
$
|
1.55
|
|
|
$
|
1.39
|
|
|
$
|
0.85
|
|
|
Diluted
|
|
$
|
1.10
|
|
|
$
|
1.54
|
|
|
$
|
1.39
|
|
|
$
|
0.84
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three Months Ended
|
||||||||||||||
|
|
|
March 31,
2014 |
|
June 30,
2014 |
|
September 30,
2014 |
|
December 31,
2014 |
||||||||
|
Net sales
|
|
$
|
1,027,676
|
|
|
$
|
998,576
|
|
|
$
|
1,253,227
|
|
|
$
|
1,135,871
|
|
|
Gross profit
|
|
287,010
|
|
|
305,971
|
|
|
361,520
|
|
|
362,849
|
|
||||
|
Income from operations
|
|
248,055
|
|
|
266,788
|
|
|
306,761
|
|
|
302,387
|
|
||||
|
Net income attributable to
Westlake Chemical Corporation
|
|
158,032
|
|
|
169,443
|
|
|
167,757
|
|
|
183,291
|
|
||||
|
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
1.18
|
|
|
$
|
1.27
|
|
|
$
|
1.26
|
|
|
$
|
1.38
|
|
|
Diluted
|
|
$
|
1.18
|
|
|
$
|
1.26
|
|
|
$
|
1.25
|
|
|
$
|
1.37
|
|
|
(1)
|
Basic and diluted earnings per common share ("EPS") for each quarter is computed using the weighted average shares outstanding during that quarter, while EPS for the year is computed using the weighted average shares outstanding for the year. As a result, the sum of the EPS for each of the four quarters may not equal the EPS for the year.
|
|
(a)(1)
|
The financial statements listed in the Index to Consolidated Financial Statements in Item 8 of this Form 10-K are filed as part of this Form 10-K.
|
|
|
|
|
(a)(2)
|
The following schedule is presented as required. All other schedules are omitted because the information is not applicable, not required, or has been furnished in the Consolidated Financial Statements or Notes thereto in Item 8 of this Form 10-K.
|
|
Accounts Receivable Allowance for Doubtful Accounts
|
|
Balance at
Beginning
of Year
|
|
Charged to
Expense
|
|
Additions/
(Deductions)
(1)
|
|
Balance at
End of
Year
|
||||||||
|
2015
|
|
$
|
13,468
|
|
|
$
|
956
|
|
|
$
|
(329
|
)
|
|
$
|
14,095
|
|
|
2014
|
|
11,741
|
|
|
301
|
|
|
1,426
|
|
|
13,468
|
|
||||
|
2013
|
|
11,172
|
|
|
5,514
|
|
|
(4,945
|
)
|
|
11,741
|
|
||||
|
(1)
|
Primarily accounts receivable written off during the period.
|
|
(a)(3)
|
Exhibits
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
2.1
|
|
Share Purchase Agreement dated as of May 28, 2014 by and among Westlake Germany GmbH & Co. KG and various entities associated with Advent International Corporation (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
|
|
3.1
|
|
Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on August 6, 2004 (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
|
|
3.2
|
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on May 16, 2014 (incorporated by reference to Westlake's Current Report on Form 8-K, filed on May 16, 2014, File No. 001-32260).
|
|
|
|
|
|
3.3
|
|
Bylaws of Westlake (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
|
|
4.2
|
|
First Supplemental Indenture dated as of January 13, 2006 by and among Westlake, the subsidiary guarantors party thereto and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
|
|
4.3
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
|
|
4.4
|
|
Form of 6 ¾% senior notes due 2032 (included in Exhibit 4.3).
|
|
|
|
|
|
4.5
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.6
|
|
Form of 6 ½% senior notes due 2029 (included in Exhibit 4.5).
|
|
|
|
|
|
4.7
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.8
|
|
Form of 6 ½% senior notes due 2035 (the "2035 GO Zone Notes") (included in Exhibit 4.7).
|
|
|
|
|
|
4.9
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.10
|
|
Form of 6 ½% senior notes due 2035 (the "2035 IKE Zone Notes") (included in Exhibit 4.9).
|
|
|
|
|
|
4.11
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6
5
/
8
% senior notes (incorporated by reference to Exhibit 4.6 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
|
|
4.12
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
|
|
4.13
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 16, 2012, File No. 1-32260).
|
|
|
|
|
|
4.14
|
|
Form of the Company's 3.60% Senior Notes due 2022 (included in Exhibit 4.13).
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
4.15
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
|
|
4.16
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.17
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.18
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.19
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo, LP, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
|
|
10.2
|
|
Borrower Joinder Agreement, dated as of May 1, 2013, between North American Specialty Products LLC, a Delaware limited liability company, the Existing Borrowers (as defined therein) and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 4.1 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
10.3
|
|
Loan Agreement, dated as of November 1, 2007, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
|
|
10.4
|
|
Amended and Restated Loan Agreement, dated as of July 2, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.5
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 GO Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.6
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 IKE Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.7
|
|
Form of Registration Rights Agreement between Westlake and TTWF LP (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on July 2, 2004).
|
|
|
|
|
|
10.8
|
|
Senior Unsecured Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.13 to Westlake Chemical Partners LP's Registration Statement on Form S-1 filed on June 30, 2014, File No. 1-36567).
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
10.9
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K filed on April 30, 2015, File No. 1-36567).
|
|
|
|
|
|
10.10+
|
|
Westlake Chemical Corporation 2013 Omnibus Incentive Plan (as amended and restated as of May 17, 2013) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 22, 2013, File No.1-32260).
|
|
|
|
|
|
10.11+
|
|
Form of Restricted Stock Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
|
|
10.12+
|
|
Form of Stock Option Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
|
|
10.13+
|
|
Form of Long-Term Cash Performance Award Letter effective as of February 18, 2011 (incorporated by reference to Westlake's Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 24, 2011, File No. 1-32260).
|
|
|
|
|
|
10.14+
|
|
Westlake Chemical Corporation Amended and Restated Annual Incentive Plan adopted by the Compensation Committee of the Board of Directors on March 24, 2011 (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed on May 4, 2011, File No. 1-32260).
|
|
|
|
|
|
10.15+
|
|
Form of Restricted Stock Units Award Letter effective as of February 15, 2013 (incorporated by reference to Exhibit 10.29 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
|
|
10.16+
|
|
Form of Stock Option Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
10.17+
|
|
Form of Restricted Stock Units Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
10.18+
|
|
Form of Long-Term Cash Performance Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.5 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
21†
|
|
Subsidiaries of Westlake.
|
|
|
|
|
|
23.1†
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
|
|
31.1†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Executive Officer).
|
|
|
|
|
|
31.2†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Financial Officer).
|
|
|
|
|
|
32.1†
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
|
|
99.1†
|
|
Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document.
|
|
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
†
|
Filed herewith.
|
|
+
|
Management contract, compensatory plan or arrangement.
|
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
|
|
|
|
|
|
Date:
|
February 24, 2016
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
Albert Chao, President and Chief Executive Officer
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
||
|
/
S
/ A
LBERT
C
HAO
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 24, 2016
|
|
Albert Chao
|
|
|||
|
|
|
|
||
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
Senior Vice President, Chief Financial Officer
and Treasurer (Principal Financial Officer)
|
|
February 24, 2016
|
|
M. Steven Bender
|
|
|||
|
|
|
|
||
|
/
S
/ G
EORGE
J. M
ANGIERI
|
|
Vice President and Chief Accounting Officer
(Principal Accounting Officer)
|
|
February 24, 2016
|
|
George J. Mangieri
|
|
|||
|
|
|
|
||
|
/
S
/ J
AMES
C
HAO
|
|
Chairman of the Board of Directors
|
|
February 24, 2016
|
|
James Chao
|
|
|||
|
|
|
|
||
|
/
S
/ A
LBERT
C
HAO
|
|
Director
|
|
February 24, 2016
|
|
Albert Chao
|
|
|||
|
|
|
|
||
|
/
S
/ R
OBERT
T. B
LAKELY
|
|
Director
|
|
February 24, 2016
|
|
Robert T. Blakely
|
|
|||
|
|
|
|
||
|
/
S
/ M
ICHAEL
J. G
RAFF
|
|
Director
|
|
February 24, 2016
|
|
Michael J. Graff
|
|
|||
|
|
|
|
||
|
/
S
/ D
OROTHY
C. J
ENKINS
|
|
Director
|
|
February 24, 2016
|
|
Dorothy C. Jenkins
|
|
|||
|
|
|
|
||
|
/
S
/ M
AX
L. L
UKENS
|
|
Director
|
|
February 24, 2016
|
|
Max L. Lukens
|
|
|||
|
|
|
|
||
|
/S/ R. B
RUCE
N
ORTHCUTT
|
|
Director
|
|
February 24, 2016
|
|
R. Bruce Northcutt
|
|
|||
|
|
|
|
|
|
|
/
S
/ H. J
OHN
R
ILEY
, J
R
.
|
|
Director
|
|
February 24, 2016
|
|
H. John Riley, Jr.
|
|
|||
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
2.1
|
|
Share Purchase Agreement dated as of May 28, 2014 by and among Westlake Germany GmbH & Co. KG and various entities associated with Advent International Corporation (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
|
|
3.1
|
|
Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on August 6, 2004 (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
|
|
3.2
|
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Westlake as filed with the Delaware Secretary of State on May 16, 2014 (incorporated by reference to Westlake's Current Report on Form 8-K, filed on May 16, 2014, File No. 001-32260).
|
|
|
|
|
|
3.3
|
|
Bylaws of Westlake (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on August 9, 2004).
|
|
|
|
|
|
4.1
|
|
Indenture dated as of January 1, 2006 by and among Westlake, the potential subsidiary guarantors listed therein and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
|
|
4.2
|
|
First Supplemental Indenture dated as of January 13, 2006 by and among Westlake, the subsidiary guarantors party thereto and JPMorgan Chase Bank, National Association, as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on January 13, 2006, File No. 1-32260).
|
|
|
|
|
|
4.3
|
|
Second Supplemental Indenture, dated as of November 1, 2007, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
|
|
4.4
|
|
Form of 6 ¾% senior notes due 2032 (included in Exhibit 4.3).
|
|
|
|
|
|
4.5
|
|
Third Supplemental Indenture, dated as of July 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.6
|
|
Form of 6 ½% senior notes due 2029 (included in Exhibit 4.5).
|
|
|
|
|
|
4.7
|
|
Fourth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.8
|
|
Form of 6 ½% senior notes due 2035 (the "2035 GO Zone Notes") (included in Exhibit 4.7).
|
|
|
|
|
|
4.9
|
|
Fifth Supplemental Indenture, dated as of December 2, 2010, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
4.10
|
|
Form of 6 ½% senior notes due 2035 (the "2035 IKE Zone Notes") (included in Exhibit 4.9).
|
|
|
|
|
|
4.11
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6
5
/
8
% senior notes (incorporated by reference to Exhibit 4.6 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
|
|
4.12
|
|
Supplemental Indenture, dated as of December 31, 2007, among the Company, WPT LLC, Westlake Polymers LLC, Westlake Petrochemicals LLC, Westlake Styrene LLC, the other subsidiary guarantors party thereto and The Bank of New York Trust Company, N.A. related to the 6 ¾% senior notes (incorporated by reference to Exhibit 4.7 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2007, filed on February 20, 2008, File No. 1-32260).
|
|
|
|
|
|
4.13
|
|
Sixth Supplemental Indenture, dated as of July 17, 2012, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 16, 2012, File No. 1-32260).
|
|
|
|
|
|
4.14
|
|
Form of the Company's 3.60% Senior Notes due 2022 (included in Exhibit 4.13).
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
4.15
|
|
Seventh Supplemental Indenture, dated as of February 12, 2013, among the Company, the Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.16 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
|
|
4.16
|
|
Supplemental Indenture, dated as of May 1, 2013, among North American Specialty Products LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.17
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake Pipeline Investments LLC, a Delaware limited liability company, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.18
|
|
Supplemental Indenture, dated as of June 1, 2013, among Westlake NG IV Corporation, a Delaware corporation, and Westlake NG V Corporation, a Delaware corporation, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
4.19
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo, LP, the Company, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed on August 6, 2014, File No. 1-32260).
|
|
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
|
|
10.2
|
|
Borrower Joinder Agreement, dated as of May 1, 2013, between North American Specialty Products LLC, a Delaware limited liability company, the Existing Borrowers (as defined therein) and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 4.1 to Westlake's Current Report on Form 8-K, filed on March 29, 2013, File No. 1-32260).
|
|
|
|
|
|
10.3
|
|
Loan Agreement, dated as of November 1, 2007, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 18, 2007, File No. 1-32260).
|
|
|
|
|
|
10.4
|
|
Amended and Restated Loan Agreement, dated as of July 2, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority (incorporated by reference to Westlake's Current Report on Form 8-K, filed on July 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.5
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 GO Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.6
|
|
Loan Agreement, dated as of November 1, 2010, by and between the Company and the Louisiana Local Government Environmental Facilities and Community Development Authority, relating to the 2035 IKE Zone Notes (incorporated by reference to Westlake's Current Report on Form 8-K, filed on December 8, 2010, File No. 1-32260).
|
|
|
|
|
|
10.7
|
|
Form of Registration Rights Agreement between Westlake and TTWF LP (incorporated by reference to Westlake's Registration Statement on Form S-1/A, filed on July 2, 2004).
|
|
|
|
|
|
10.8
|
|
Senior Unsecured Revolving Credit Agreement between Westlake Chemical OpCo LP and Westlake Development Corporation (incorporated by reference to Exhibit 10.13 to Westlake Chemical Partners LP's Registration Statement on Form S-1 filed on June 30, 2014, File No. 1-36567).
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
10.9
|
|
Senior Unsecured Revolving Credit Agreement by and among Westlake Chemical Partners GP LLC and Westlake Chemical Finance Corporation, dated as of April 29, 2015 (incorporated by reference to Exhibit 10.1 to Westlake Chemical Partners LP's Current Report on Form 8-K filed on April 30, 2015, File No. 1-36567).
|
|
|
|
|
|
10.10+
|
|
Westlake Chemical Corporation 2013 Omnibus Incentive Plan (as amended and restated as of May 17, 2013) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 22, 2013, File No.1-32260).
|
|
|
|
|
|
10.11+
|
|
Form of Restricted Stock Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
|
|
10.12+
|
|
Form of Stock Option Award Letter for Special February 2007 Awards (incorporated by reference to Westlake's Current Report on Form 8-K, filed on March 1, 2007, File No. 1-32260).
|
|
|
|
|
|
10.13+
|
|
Form of Long-Term Cash Performance Award Letter effective as of February 18, 2011 (incorporated by reference to Westlake's Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 24, 2011, File No. 1-32260).
|
|
|
|
|
|
10.14+
|
|
Westlake Chemical Corporation Amended and Restated Annual Incentive Plan adopted by the Compensation Committee of the Board of Directors on March 24, 2011 (incorporated by reference to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed on May 4, 2011, File No. 1-32260).
|
|
|
|
|
|
10.15+
|
|
Form of Restricted Stock Units Award Letter effective as of February 15, 2013 (incorporated by reference to Exhibit 10.29 to Westlake's Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 22, 2013, File No. 1-32260).
|
|
|
|
|
|
10.16+
|
|
Form of Stock Option Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.3 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
10.17+
|
|
Form of Restricted Stock Units Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.4 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
10.18+
|
|
Form of Long-Term Cash Performance Award Letter for 2015 Executive Officer Awards (incorporated by reference to Exhibit 10.5 to Westlake's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, File No. 1-32260).
|
|
|
|
|
|
21†
|
|
Subsidiaries of Westlake.
|
|
|
|
|
|
23.1†
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
|
|
|
|
31.1†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Executive Officer).
|
|
|
|
|
|
31.2†
|
|
Rule 13a-14(a) / 15d-14(a) Certification (Principal Financial Officer).
|
|
|
|
|
|
32.1†
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer).
|
|
|
|
|
|
99.1†
|
|
Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document.
|
|
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
†
|
Filed herewith.
|
|
+
|
Management contract, compensatory plan or arrangement.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|